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ABSTRACT 
The use of Advanced Data Analytics Techniques like Machine Learning and its appliance 
to the medical area has been a long waited promising phenomenon. Electronic Medical 
Record databases hold out the promise of using the clinical patient data stored in these 
databases to apply machine learning algorithms that can provide models to better predict 
patient conditions in advance. 
In this thesis we intend to tackle a very serious phenomenon that is Hospital Acquired 
Infection caused by Multi Drug Resistant bacteria in a General Hospital environment. 
Based on the automatic extraction of thousands of clinical variables that are stored daily in 
the patient’s Electronic Medical Record (or that can be calculated from it), combined with 
Machine Learning techniques we tried to develop predictive models that are able to weight 
and model the hidden contribution that the correlation and evolution of each of these 
variables represents to the risk of developing a Multi Drug Resistant bacteria in the 
following 72 hours of an inpatient day. Therefore, we developed an automated approach 
that intends to demonstrate that it is possible to generate predictive models with satisfactory 
predictive power to be used in clinical practice, as a complement of the manual, subjective 
and biased process that is currently in place, i.e. the physician’s empirical judgement. 
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1. INTRODUCTION 
This chapter begins with a high-level overview of the problem to be addressed. Next, the 
research questions that will drive this work are stated. Before moving forward, a literature 
review regarding the problem to be addressed is exposed, in order to increase the 
knowledge about the problem and, also, to sign the motivation to develop this work. The 
chapter ends with a high level description of the plan that is going to be followed to 
develop this research. 
1.1 PROBLEM OVERVIEW 
In April 2014, the World Health Organization (WHO) announced the results of its first 
global report on antimicrobial resistance. The report stated that antibiotic resistance is a 
worldwide threat to public health and is happening right now, in every region of the world, 
with the potential to affect anyone, of any age, in any country (World Health Organization, 
2014). As a consequence, the appearance of a series of Multi Drug Resistant (MDR) 
bacteria poses a difficult task for physicians, who have limited therapeutic options. 
Particularly, Hospital Acquired Infections (HAIs) are frequently caused by MDR bacteria 
and are a major threat to patient safety (Aranaz et al., 2008; Nascimento et al., 2013). 
Those infections that are caused by MDR microorganisms are of special concern because 
they impose additional morbidity, mortality and costs, due to the patient’s immune system 
vulnerability during his/her hospital stay (Cornejo et al., 2014; Tacoconelli, 2006; Lambert 
et al., 2011). In Portugal, a study from Fiorentino (2014) reveals that HAIs result in average 
extra costs, per patient, between 7,930.84€ and 11,230.42€; an extra average length of stay 
between 20 and 25 days; and expected difference of mortality rate between 8.58% and 
18.18%.  
The rise of resistance, together with the shortage of new broad-spectrum antibiotics, 
underlines the urgency of optimizing the use of available drugs. Nevertheless, much of the 
process that goes from suspecting that the patient has caught a HAI MDR bacteria to 
choosing the right antibiotic treatment, remains empiric (Burke, 1998; Sedighi et al., 2014). 
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Usually, even before the patient’s microbiological lab sample is requested, or while these 
results are still being published, which takes 3 to 5 days after the request, the antibiotic 
treatment process has already started. Physicians, relying only on their empirical 
experience, usually start antibiotic therapy before lab results are published. However, HAI 
MDR bacteria events bring more complexity in the empirical treatment of these infections, 
as this first-hand approach might not result (Sedighi et al., 2014).  
The window of time that goes from the infection suspicion to the lab’s definitive 
confirmation of the microbiological agent represents an opportunity to develop new data 
driven approaches that can help physicians to predict the species and resistance profile of a 
HAI MDR bacteria. Predictive models in these areas could help physicians to be more 
efficient in their daily activity of treating infections and applying the right antibiotic earlier, 
even before the lab results are published. 
Currently, the clinical practice generates exchanges and stores huge amounts of clinical 
information about each patient encounter that is not being fully leveraged. In addition to the 
traditional clinical notes, databases in modern hospitals automatically capture structured 
data relating to all aspects of care, including laboratory test results, diagnosis, medication 
and imaging data. With the astonishing capabilities of the more recent Machine Learning 
Algorithms (Domingos, 2015), this poses a real opportunity to apply Machine Learning 
(ML) in medical practice and to predict harmful events like a HAI caused by a MDR 
bacteria. 
This thesis intends to demonstrate that, in an acute care general hospital scenario, where 
patient records are mostly electronic and based on Electronic Medical Record (EMR) 
software, the use of automated models, that can leverage the systematic and fast analysis of 
hundreds of patient variables stored in these databases, might be helpful in predicting HAI 
caused by MDR bacteria earlier. These models can also be important to help identifying 
potential predictors for the presence of MDR bacteria and, therefore, contribute to the 
development of new clinical guidelines and systematic approaches to this phenomenon. In 
that sense, major objectives of this thesis are: 
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1. To develop a predictive model for HAI MDR bacteria in the next 72 hours of an 
inpatient episode. This can help clinicians to match high-risk patients with the 
appropriate interventions or therapies (e.g. antibiotics) earlier than current practice 
which is heavily dependent on the doctor’s intuition, while waiting for the 
microbiological lab results that usually take several days to be published. 
2. To develop a fully automated approach using BigData, that can extract the patient’s 
electronic information stored in hospital databases (ex: EMR’s) and automatically 
feed a predictive model for HAI MDR bacteria with the existing electronic data. 
This model is meant to be run on every inpatient day and it is expected to update its 
predictions for every single day the patient is at the hospital. 
3. To find new variables that might have predictive power for HAI MDR and which 
can be unknown to the clinicians, thus contributing to refine clinical guidelines 
currently in use. 
4. To develop an automated approach to build and update a complex and multifactorial 
clinical dataset, with more than 1500 clinical variables, that may be used to train 
and develop other predictive models more rapidly in the future. For instance, a 
predictive model for predicting Intensive Care Unit (ICU) admissions could be built 
faster, as the dataset used for this thesis will capture much of the multidimensional 
variables that characterize a patient in several clinical events of interest (vital signs, 
medication, lab results, previous episode history, among others). 
The main goal of this thesis is to build an automated patient risk-stratification model for 
HAI MDR bacteria in the next 72 hours, based merely on the variables coming from the 
patients EMR and also relying on ML algorithms capabilities. However, as all the data that 
will be used to feed this models will come from real EMR data, and not from curated 
datasets, the successful development of these risk-stratification models will present several 
challenges as far as accuracy is concerned (Wiens, 2014), namely: 
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 Real Data: The data that will be used to build the predictive models will be real 
data coming from the patient’s EMR. Therefore, it is expected to obtain several 
inconsistencies and missing values. The quality of data in EMRs, in which 
information is often missing from structured fields or is incorrect, poses a serious 
obstacle to the development of this kind of clinical decision support system. 
 High Dimensionality: In each inpatient day, a patient can have hundreds of 
different variables representing his/her episode, from a clinical point of view. Some 
of these variables will have different degrees of contribution and correlation with 
the patient’s risk for nosocomial infection. 
 Temporal Characteristic: Some patient variables will be time-independent (ex: 
sex) while others will have high importance only in a specific timeframe (ex: blood 
pressure). Besides, all the patient data are not registered at the same time; for 
instance, vital signs can be measured every day or three times a day, while blood 
results might only be requested one time per week for some patients, and 7 times 
per week for other patients. These time-varying data suggest that, as a patient 
spends time in the hospital, his/her actual risk of acquiring a HAI MDR bacteria 
will also vary. All these temporal aspects represent additional challenges. 
 Unbalanced Data: This thesis intends to predict HAI MDR in the next 72 hours of 
each inpatient day. The object of interest is very infrequent with relation to the 
alternate objects (patients without MDR infection). Dealing with this kind of 
unbalanced dataset and predicting the minority class is frequently a challenge. The 
absence of strategies to address unbalanced data inevitably leads the algorithms to 
learn to over identify common-class data and will constrain the efforts to understand 
meaningful patterns across rare cases or within rare classes of data (Bradley, 2016). 
Some of the techniques that might be used in this thesis to deal with this kind of 
challenges are related to 1) corrective data sampling to create a more balanced 
dataset; or 2) the use of costs to force the modeling algorithm to focus on cost 
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minimization, rather than on maximizing first-pass accuracy (cost-sensitive 
learning).  
1.2 RESEARCH QUESTIONS 
We address the above-mentioned problem by formulating the following research questions: 
Question 1: Can we build predictive models using the best ML algorithms and a Big Data 
(“More Data Beats Better Algorithms”) approach in order to provide insights about 
hospitalized infected patients with MDR bacteria, in advance, and help clinical teams to 
anticipate actions on these patients? 
Question 2: By only using data coming from electronic medical data stored in hospital 
databases, will it be possible to assess all hospitalized patients, in every inpatient day and, 
return a robust prediction about any patient being infected with a MDR bacteria in the 
following 72 hours? Will the available data be enough in order to teach predictive models 
how to distinguish patients that will be infected with MDR bacteria from those who will 
not? 
Question 3: In the timeframe of this Research, which models could be built with 
satisfactory prediction performance, from a clinician standpoint, so that they would be used 
in clinical practice? What could be a satisfactory model for clinicians?  
Question 4: In the timeframe of this Research, while testing and developing predictive 
models, would we be able to fully automate some predictive models and bring them to 
production in the day after of presenting this work? Can these models be run every day 
(24h/7h), in a real-life hospital production scenario, in a short time?  
In Question 1 we intend to test if the latest ML algorithms, that are proving to be very 
successful in terms of their predictive power and generalization capabilities, can also help 
in predicting infected patients with HAI MDR bacteria, by using Multidimensional 
Datasets. These datasets will be constructed from the data electronically stored about 
hospitalized patients. In the search for the answer to this question, we intend to test some of 
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the algorithms that played a key role in getting a top 10 ranking in more than 15 Kaggle 
competitions (Kaggle, 2016; Conort, 2014). The datasets used will be “Big Data” datasets 
with more than 1000 physiological variables stored in electronic databases about each 
patient, measured in each inpatient day, during one year of inpatient episodes. 
In Question 2 the main issue is related with the datasets used to train the models. The 
definition of case, i.e, Positive (Infected Patients) and Negative (Not infected Patients) is 
crucial here. If the models start to learn in a biased and inconsistent dataset, the chance to 
obtain good predictive models is lower. Therefore, this research needed to obtain 
representative samples of the objective it is was trying to achieve.  
In Question 3 the main concern is finding if, throughout this work, it will be possible to 
build a “good-enough” predictive model from a clinician standpoint. This is absolutely 
crucial since this work intends to achieve adherence from the clinicians inside a hospital. 
Therefore, the metrics that assess the predictive power of each model and its robustness to 
generalization needed to be satisfactory for clinicians and clearly understood by them. To 
address this question we will not account for model interpretability. We will concentrate all 
the efforts in trying to find if we can build a model with good predictive performance, and 
leave interpretability issues for future research.  
In Question 4 we hypothesized if a predictive model could be built in order to run every 
day (24h/7h), in a real-life hospital production scenario, by using only the available data in 
the electronic databases about each inpatient day. This involves developing a model taking 
into consideration the need to integrate it with hospital information systems and front-end 
tools. Besides, we also need to consider the cost of the tool to use, ease of use and learning 
curve necessary for the development team, and also the potential to further develop these 
models and benefit from the latest packages being released every day in the ML 
community. Moreover, there is another very important aspect when building a model to run 
live in production everyday: “We need to assure that all the variables used to learn the 
predictive model are variables that will be already available at the time of the prediction”. 
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This means an increased effort to select the exact time of the day where the model would 
run and accounting for the variables that would be available for sure. 
1.3 LITERATURE REVIEW: MAIN LINES 
A literature review evidences that some previous work about building models for predicting 
HAI already exists, but most of these models are based on predicting a single 
microbiological agent, usually Clostridium Difficile related Infections (Wiens, 2014; 
Wang, 2015). Other experiences and predictive models are focused on detecting only if the 
patient has a HAI and the specific microbiological agent is not taken into account, thus, the 
records are only classified into “HAI” and “No HAI” records (Dalianis et al., 2015). Usual 
approaches for predicting HAI using electronic data are based on variables captured from 
the clinical text, body temperature data, drug lists data and microbiology reports in the 
EMR, but there is no evidence of a fully automated system like the one we are proposing.  
In the simplest data mining tasks, i.e., to classify the patient records into “HAI” and “No 
HAI” records, some works demonstrate that the Random Forest (RF) algorithm could 
obtain 87% recall and 83% precision (Ehrentraut, 2014). Other works compared the 
application of Naïve Bayes (NB), Support Vector Machines (SVM) and a C4.5 Decision 
Tree to classify the patient records into “HAI” or “No HAI”, and conclude that the results 
of the three classification tasks were overall similar; while SVM yielded the highest recall 
91% with the best overall performance, i.e., a F2-score of 87.4% (Ehrentraut, 2012). 
To be helpful in predicting HAI caused by MDR bacteria in a real clinical practice scenario, 
ML techniques need to be more personalized and to detect the specific type of bacteria and 
resistance that is causing the HAI. As most of the works that were previously done about 
this subject tend to focus on predicting a single type of bacteria, they usually become of 
limited use in real-life scenarios, where serious HAI can be caused by a variety of MDR 
bacteria.  
This thesis intends to introduce a new approach to current practice, i.e., one that will try to 
build a model to help to predict if the patient will develop a hospital-acquired infection 
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caused by several kinds of important MDR bacteria, in the next 72 hours. We expect this 
solution to be more useful to physicians than current decision support algorithms in the area 
of HAI.  
One of the most interesting aspects of the literature review in any work related to HAI is to 
guide us towards the correct pathway as far as feature selection is concerned. In that sense, 
some previous works from Wiens (2014), Guillamet and Kollef (2015), Näsman (2013) and 
Ehrentraut (2012) revealed the most important features that worked in their predictive 
models for nosocomial infection. Some of these features are shared across all the works. 
For instance, some of the features commonly used in these previous machine learning 
studies, are: 
 Demographics: patient age and gender; 
 Underlying health status: if the patient status requires hemodialysis; 
 Current health status: “fever” and “previous colonization by MDR 
microorganism”; 
 Invasive devices: what kind of invasive devices are used (central vein, catheter, 
among others); 
 Types of drugs administered and therapy duration: special focus on: “days with 
anti-parasitics”, “days with antibiotics”, “days with corticosteroids”, “days with 
cytotoxics”, “days with immunosuppressants”. For instance, immunosuppression 
significantly increases the likelihood of infection with MDR Gram-negative bacteria 
and Methicillin Resistant Staphylococcus Aureus (MRSA). Moreover, antibiotic 
history is known to increase the probability of infection. 
 Physical Area: type of wards where the patient was during his/her hospitalization; 
 Miscellaneous: length of stay, transfer from another hospital, etc. 
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From the work of Guillamet and Kollef (2015) it becomes clear that, for instance, variables 
as “previous antibiotic use” appear to be the most important risk factor for MDR infection. 
This phenomenon is clinically explained as it creates an intricate pattern of resistance, not 
only by selecting resistant or mutant clones, but also by inducing unexpected defense 
mechanisms against different classes of antimicrobials in various species of microbes. 
Given its importance, this feature is a perfect example of one of the first features that will 
be included in the model that will be developed in this thesis.  
The work of Wiens (2014) was very inspiring, in several aspects. One of them was related 
to an interesting variable that was created in this work, to account for the patient exposure 
to a disease, called “colonization pressure”. Using an objective and measurable approach, 
Wiens (2014) demonstrated that we could combine variables and obtain a measure that 
accounts for the patient exposure to an infection. This could help develop better predictive 
models for infection and, in that sense, we used this reasoning to include similar variables 
in our model, with our own approach to the problem.   
All the previous features that were mentioned in previous machine learning studies are just 
an additional insight to approach our problem. In reality, we intend to use several other 
features and to apply multiple ML algorithms to identify the important features from the 
data and use them to create predictive classifiers. 
1.4 PLAN FOR THE THESIS 
High-Level Methodology 
This thesis intends to follow the Cross-Industry Standard Process for Data Mining (CRISP-
DM) methodology (CRISP-DM, 2013). We believe that this is the most correct approach to 
use in this thesis and, especially, to be applied in the healthcare scenario because it begins 
by the most fundamental phase at solving a business problem in healthcare: The Business 
Understanding. In that sense, as this thesis intends to help developing new approaches 
based on ML to predict HAI MDR bacteria, it is crucial to first get a deep understanding of 
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the Business Problem and, therefore, we expect to conduct a series of interviews in order to 
ask clinicians some very important questions, such as: 
 “What is a MDR bacteria?” 
 “How do doctors behave in their clinical practice when faced with an infected 
patient? What part of their actions is still empirical?” 
 “When do they suspect that the patient caught a HAI infection?” 
 “What are the signs that the patient presents when he/she has caught a HAI? What 
part of these signs might already be stored or could be induced from the patient’s 
EMR?” 
This process of Business Understanding will be preceded by a literature review in the 
clinical area of MDR infection and antibiotics use. This previous knowledge of the 
Business is essential to have success in interviewing clinicians. Clinicians are usually not 
prepared to think from an engineering point of view and to explain their usual practice by a 
set of mathematical rules format, as engineers usually do. Therefore, we should lead them 
to explain their practice in a way that could help finding out the business rules. 
One of the most fundamental challenges in this thesis is that it requires a huge time 
investment in the Data preparation phase, as we relied on the assumption seen on the 
literature review that “better data often beats better algorithms” (Edwin, 2011). We intend 
to develop a multidimensional dataset that is going to be based on several variables that 
will be automatically captured from the EMR, the Lab system and the Pharmacy system of 
a major acute Hospital (figure 1). 
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Figure 1: Automated Approach to obtain phenotyping information 
We intend to represent each day of a patient’ admission as a high-dimensional feature 
vector, composed of both variables collected once at the time of admission, and those that 
continue to be measured over the course of the hospitalization. Each case in the final 
dataset (rows) will be defined as a patient ID combined with the patient’s inpatient day 
(patient ID + inpatient day). With this approach it is expected to obtain a high dimensional 
view of the patient and increase the probability of developing a successful predictive model 
based on ML techniques. The dataset will be described in more detail in the following 
chapters of this thesis. 
Architecture  
As previously exposed in Research Question number 4, one of the main objectives of this 
thesis is the development of a real live working model for predicting HAI MDR bacteria in 
the next 72 hours. This model would be run every day (24h/7h), in a real-life hospital 
production scenario.  
We imagine a scenario where the inpatient physician, while suspecting the patient is 
infected, decides to order for microbiological lab results. In a typical hospital scenario, the 
physician will wait for at least 3 days for these results. While requesting for 
microbiological lab analysis, simultaneously, an order would also be sent to our ML 
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Algorithm requesting an “intelligent” prediction about the results of this microbiological 
lab analysis being requested.  
In terms of the variables needed to train this model for accurate predictions, this would 
involve using Big datasets coming from several hospital information systems. In our case, 
the raw data, coming from these information systems, is already being captured in near 
real-time and centralized in the hospital’s Data Warehouse. In figure 2 we try to give an 
overview of the architecture of this proposed system. 
 
Figure 2: Overview of the Architecture of this Automated System 
Temporal Plan 
To accomplish this thesis objectives, a temporal plan was drawn, considering the huge 
challenges of developing an automated approach to help doctors tackle some of the most 
fundamental issues in a hospital’ scenario, i.e. nosocomial infection. The plan also accounts 
for the author’s lack of time to be fully dedicated to this thesis, as all the work is done after 
daily business work and during late nights and weekends. In that sense, from a planning 
and implementation point of view, a lot of time is intended to be dedicated to Business 
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Understanding. The theme of this thesis involves a very serious, critical and hard to predict 
problem, “nosocomial infection”, thus, the need to involve the business users (doctors 
mostly) and to get deep into the subject right from the begging is absolutely crucial.  
The Data Extraction, Correlation and Understanding phase is also one of the tasks that will 
take more time from this thesis. There are a lot of data quality issues at stake, when a real 
time predictive model is meant to be built and used in a healthcare environment, thus 
emphasizing the importance of spending a lot of time in the understanding and data 
preparation phases. Meetings with clinicians will proceed throughout the thesis, clinically 
reviewing each step results, while the algorithms continue to be tested and tuned with the 
help of the thesis supervisor. 
 
Figure 3: Timeline of the Thesis Plan with Milestones and Tasks to Accomplish 
The final phase of this thesis will be related to the modelling procedures, trying to develop 
and evaluate a predictive model for HAI caused by MDR bacteria. In this phase we will try 
to absorb lessons learned from other healthcare prediction models originated from data 
competitions, clinical studies or clinical models. Also, some ML tricks from the  2011 
Knowledge Discovery and Data Mining Competition (KDD, 2011)  best industry papers 
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will be taken into account, together with blogs about machine learning containing tips that 
focus on the mistakes that should be avoided in the ML process. To speed up the process of 
developing this model, we will try to exploit some the most used R packages in data 
science competitions like Kaggle (Kaggle, 2016). 
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2. DATA MINING PROBLEM  
2.1 BUSINESS PROBLEM UNDERSTANDING 
The prevalence of antimicrobial resistance is skyrocketing and leading to the appearance of 
the dangerous MDR bacteria. In a hospital’ scenario, frequent usage of antibiotics 
facilitates the emergence and spread of resistant strains and leads to high resistance levels; 
at the same time the patients are especially vulnerable, thus, the risk of being infected by a 
MDR bacteria is higher (Abel et al., 2014). Besides the patient’s clinical condition, which 
obviously influences the efficiency of his/her immune response to microorganism’s 
invasion, there are multiple causes that lead the patient to be at risk of getting a hospital-
acquired infection.  
Most of HAIs are due to a lack of hygiene from clinical staff during the several moments of 
contact with the patient, where hand hygiene is crucial (Figure 4). For more than 150 years, 
the correlation between hand hygiene improvement and healthcare-associated infection 
reduction has been proved and hand hygiene is widely accepted as a main component of 
infection prevention (Ellingson, 2014). 
 
Figure 4: World Health Organization’s - 5 Moments for Hand Hygiene in acute care settings. 
Reproduced from “Five Moments for Hand Hygiene,” World Health Organization, 2009, 
http://www.who.int/gpsc/tools/Five_moments/en/, accessed February 2016. All rights reserved. 
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Globally, 8% of hospital stays result in HAI (World Health Organization, 2005). 
Furthermore, it has been estimated that 70% of these are caused by single- or multiple-
resistant bacteria (Livermore, 2003). Patient treatments can be tailored to the infectious 
agent and its resistance profile as soon as microbiological cultures are available. However, 
in the meantime, the physician needs to instantaneously initiate the treatment when he 
suspects the patient has an infection. This treatment phase is called empirical therapy (Abel 
et al., 2014; Leibovici et al., 1999).  
Currently, in single hospitals or wards, population-wide empirical treatment of patients can 
be coordinated, as well as several other strategies that have been proposed to fight 
resistance (Abel et al., 2014). When this empirical therapy is not adequate, antibiotic 
resistance can occur. Besides, the use of antibiotics is not free from risks. Severe side 
effects have been associated with antibiotic use, thus, they should be used wisely and for 
short time periods (Leibovici et al., 1999).  
The empirical therapy phase of a patient’s treatment is highly biased by the physician’s 
years of experience and, therefore, represents an opportunity to apply novel predictive 
models based on the existing electronic data, which might help to predict the species and 
resistance of a MDR bacteria before the lab results are revealed. If this model worked well, 
it would complement the physician’s experience and reduce the risk of choosing the wrong 
antibiotic for a patient. Particularly, the problem to be studied in this thesis will focus on 
predicting some of the most important MDR bacteria, more specifically on some of the 18 
types of MDR bacteria that were outlined as the top 18 drug-resistant threats to the United 
States, in a report published by the Center for Disease Control and Prevention (CDC) in 
2013 (CDC, 2013). 
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Figure 5: Centers for Disease Control and Prevention - CDC’s Antibiotic-Resistant Threats 
in the United States, 2013. Reproduced from “ANTIBIOTIC RESISTANCE THREATS in 
the United States, 2013” Centers for Disease Control and Prevention, 2013 
http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf accessed February 2016. 
All rights reserved. 
As this thesis intends to develop a predictive model that is meant to be used in a Portuguese 
acute general hospital, the concept of MDR bacteria was adapted from the CDC’s report to 
the European’ Scenario, by using a Portuguese Clinical Norm. On February 02, 2013, a 
Clinical Guideline implementing the Epidemiologic Surveillance of Antibiotic Resistance 
(Norm Number “004/2013”, Approved on 21/02/2013) was released by the Portuguese 
General Health Coordination, i.e.  Direção Geral de Saúde (DGS) in Portuguese (DGS, 
2013). This norm is aligned with the European Commission efforts to fight Antibiotic 
Resistance and intends to give insights about how to classify and Report MDR bacteria 
events into “alert” and “concerning” types. 
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2.2 UNDERSTANDING THE BUSINESS USER 
As with any marketing activity, before choosing the problem to address, we first tried to 
understand the customer needs. Any innovative idea is only creating value to the extent that 
it (1) addresses a relevant customer problem and (2) is adopted by the customer. In that 
sense, before starting to collect data about the business problem, this thesis involved a 
preliminary work of exploring “value” from the customer perspective.  
The process of exploring the customer perspective is an ongoing work that happens in 
several phases throughout this thesis. It begins by a Business Users Interview but, as the 
time goes one and some results are starting to appear, several follow up interviews are 
needed in order to get feedback from clinicians for the results that we are exposing. Then, 
after this feedback loop, the model is reviewed to account for particular errors that it might 
have, mostly biases that the training data can induce as the model does not have any prior 
knowledge of the data. This is an ongoing process that should work in loop, delivering 
several versions of the model to hear, from the physicians’ experience, if we are closer to a 
model that is useful in clinical practice. This cycle is exposed in Figure 6. 
 
Figure 6: Feedback Loop with the collaboration of the Business Users 
Interview with 
Physicians to 
discuss the model 
results and obtain 
feedback about 
potential mistakes
The predictive 
model is reviewed 
to locate the errors 
source
New Results are 
shown to 
Physicians
First Model 
Results are 
available
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2.3 BUSINESS USERS INTERVIEW 
We had the privilege to arrange a meeting with some senior and experienced infectologists 
in order to improve his knowledge about the Business Process of treating an infected 
patient after an initial suspicion. In fact, clinical reasoning is complex and there is a mixture 
of empirical thinking and science when the physician decides to treat a patient. From the 
very beginning of the meeting, it was possible to obtain from the physicians a written 
drawing of the factors they get into account when they suspect the patient is infected (figure 
7): 
 
Figure 7: Print of Physicians Drawing while explaining of factors that Physician take into account 
when presented with patients with Infection Signs 
From figure 7 it is possible to understand that physicians try to narrow their choices and 
exclude hypothesis in a staircase way of thinking. After this process, we tried to draw a 
diagram of how these physicians apply their empirical thinking in clinical practice 
scenarios when facing patients with infection signs (figure 8). 
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Figure 8: Empirical Thinking Process of a Physician when facing patients with Infection Signs 
From figure 8 it is possible to understand, for instance, that physicians take history of 
antibiotics as a very important factor for deciding how to judge the risk and treat a patient 
with infection signs. Also, the location of the infection seems to be a key aspect that drives 
all further decisions. This led us to conclude that the predictive model would have to be 
adjusted to the physical location of the infection, because physicians clearly treat infections 
differently, accordingly to the infection location. 
After some time spent with these infectologists, we tried to explain the objective of his 
research and the idea of applying algorithms to predict if the patient might become infected 
with a HAI MDR bacteria in advance. Immediately, the infectologists started to ask 
questions about how we were thinking to distinguish positive from negative cases of 
infected patients, i.e, the definition of “case” from a Machine Learning perspective. This 
was really crucial for the definition of the case in our research, because the doctors 
confirmed that we would make a significant mistake if we considered negative cases as “all 
cases without lab results or with negative lab results”. It soon became clear that, if we used 
this concept of “negative cases”, we would have a lot of positive examples among the 
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negative ones. Although less common, even when talking about patients with negative 
confirmed lab results, it could also happen that these cases were positive ones. This might 
happen due to bad collection of blood, urine or respiratory tract samples. We decided to 
assume this error rate and consider negative cases as those cases which had negative lab 
results. 
 
Figure 9: Print of Physicians Notes while explaining what a positive (+) and negative (-) lab result 
might mean to change clinical decisions 
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2.4 BUSINESS PROBLEM MODELLING  
To clearly separate positive instances, i.e., those patients who caught some kind of Hospital 
Acquired MDR bacteria from patients who were found to be negative and did not caught 
this bacteria, we faced several doubts during the course of this work. This implied an 
iterative process of refinement of the problem to be modelled, which is further detailed in 
Appendix 1. 
In the literature, some authors suggest an approach that classifies positive cases as the ones 
having a culture with a HAI MDR agent; while negative cases as all other patients that had 
at least one negative culture (Nascimento et al., 2013).  
After conducting interviews with the Business Users (Doctors) and reviewing the literature 
several times, we decided to adopt the following strategy to model this business problem: 
Positive Cases: All cases having a culture with a positive result for a HAI MDR agent in 
the following 72 hours from the current inpatient day (case is defined as the combination of 
the episode ID and the inpatient day), with respect to the biological product in which we are 
trying to predict (Blood, Urine or Bronchial Secretions). 
Negative Cases: All cases having a HAI culture, regardless of its result, in the following 72 
hours from the current inpatient day, with respect to the biological product in which we are 
trying to predict (Blood, Urine or Bronchial Secretions).  
The concept of HAI that we choose for the purpose of this thesis was determined by using a 
fairly common rule for defining hospital versus community acquired infection, i.e., we will 
only considered positive cultures if they occur 3 days after admission to the hospital (Trick 
et al., 2004).  
In simple terms, technically speaking, our model aims to “predict the probability of a 
positive result associated with HAI MDR bacteria, if the physician requests for a 
microbiological analysis in the following 72 hours of the current inpatient day”. 
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3. DATA EXTRACTION, CORRELATION AND 
UNDERSTANDING 
3.1 DATA EXTRACTION AND CORRELATION 
The steps related to Data Gathering and Data Modelling for the Final dataset were some of 
the most time-consuming steps in this thesis, together with the Feature Engineering step. 
Gathering the data involved, correlating more than 100 relational tables, more than 5000 
lines of SQL coding and modelling the Data for the final Dataset, took two working 
months. 
The Raw Data 
Surgical Procedures: In the EMR, procedures are encoded using ICD-92 procedure codes. 
Each row entry in the procedures table, records a procedure, the corresponding episode 
(visit) and a procedure date and time. Usually the surgical team inserts the ICD9 codes in 
the following hours after the surgery and, a few months after, these ICD9 code are 
reviewed for financial purposes. As we were trying to use only variables available at the 
time of prediction, we only used procedures inserted by the surgical teams. For this same 
reason, ICD9 “diagnosis” codes were not taken into account for our model because they are 
only inserted in the system months after the patient’s episode. 
 
Table 1: Illustrative Table of how surgeries registries are stored in hospital operational 
systems 
                                                 
2 International Classification of Diseases (9th Revision) 
EpisodeID SurgeryID TimeStamp ICD9ProcedureCode
15008481 12001858 1/3/15 9:00 AM 9035
15005889 12009532 7/3/15 3:00 PM 7431
15008329 12008130 21/8/15 3:30 PM 1232
(..) (..) (..) (..)
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Lab results: There are several types of lab results. However, in simple terms, they can be 
resumed to two major types: 
 Biochemistry - which refers to clinical biochemistry results; 
 Microbiology - which refers to microbiological cultures.  
In this work, we used biochemistry lab results to build variables for the predictors set, while 
using microbiological results to build the outcome column. Each row entry in the lab results 
table is related to biochemistry lab results and records a lab result type, a biological 
location related to the biological product collected (blood, urine, bronchial secretions 
samples, among others), the corresponding episode (visit), the measured value and a related 
timestamp, as table 2 illustrates. 
 
Table 2: Illustrative Table of how Biochemistry Lab Results are stored in hospital 
operational systems 
On the other hand, each microbiological lab result is characterized by several rows in a 
table, besides having all the fields that are registered in the biochemistry lab results 
scenario. These microbiological results have two additional columns: antibiotic type (e.g. 
vancomycin) and type of resistance of bacteria to this antibiotic type (e.g. resistant). As 
each bacteria needs to have its resistance behavior tested among several types of antibiotics 
(in order to detect MDR bacteria) there can be more than ten rows for each microbiological 
result. Table 3 illustrates how this data is stored in the lab systems database: 
EpisodeID BiochemistryLabResultType TimeStamp LabResultValue
15008481 C Reactive Protein 1/3/15 9:00 AM 98.2
15008481 Sodium 1/3/15 9:00 AM 131.0
15008481 Haemoglobine 1/3/15 9:00 AM 11.1
15008481 White Blood Cells (WBC) 1/3/15 9:00 AM 6.8
15008481 Platelets 1/3/15 9:00 AM 340.0
15008481 C Reactive Protein 1/3/15 6:00 PM NULL
15008481 Sodium 1/3/15 6:00 PM NULL
15008481 Haemoglobine 1/3/15 6:00 PM 14.3
15008481 White Blood Cells (WBC) 1/3/15 6:00 PM 7.7
15008481 Platelets 1/3/15 6:00 PM NULL
15008481 Sodium 7/3/15 9:00 AM 138.0
15008481 Haemoglobine 7/3/15 9:00 AM 8.7
15008481 Platelets 7/3/15 9:00 AM 257.0
(..) (..) (..) (..)
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Table 3: Illustrative Table of how Microbiological Lab Results are stored in hospital operational 
systems 
Regarding Microbiological Data and the objective of this thesis (predicting Multi Drug 
Resistant Hospital Acquired Bacteria), it must be said that, while extracting microbiological 
data, a hospital algorithm was used to classify the microbiological lab result and the “drug-
pathogen” interaction within two labels (YES and NO) in respect to its Multi Drug 
Resistant profile (illustration in table 4). The logic of this algorithm is complex and will not 
be further detailed as it goes beyond the main objective of this work. 
 
Table 4: Illustrative Table of how Microbiological Lab Results are treated by a hospital 
Algorithm to check if the result is MultiDrug Resistant 
Vitals: Patient vitals are stored in a similarly way when compared to lab results. Each entry 
in the vitals table corresponds to a visit (episode ID), a timestamp, a type of observation 
(e.g., Heart Rate) and a value (e.g., 130bpm). Each patient usually gets its vital signs 
measured several times a day, depending on the severity of each clinical situation. 
EpisodeID TimeStamp Type of Sample MicroorganismClass Antibiotic
Type of Resistance 
Drug-Pathogen
15008481 1/3/15 9:00 AM BLOOD Staphylococcus aureus clindamycin Resistant
15008481 1/3/15 9:00 AM BLOOD Staphylococcus aureus daptomycin Sensitive
15008481 1/3/15 9:00 AM BLOOD Staphylococcus aureus erythromycin Sensitive
15008481 1/3/15 9:00 AM BLOOD Staphylococcus aureus gentamicin Sensitive
15008481 1/3/15 9:00 AM BLOOD Staphylococcus aureus linezolid Sensitive
15008481 1/3/15 9:00 AM BLOOD Staphylococcus aureus oxacillin Sensitive
15008481 1/3/15 9:00 AM BLOOD Staphylococcus aureus quinupristin/dalpfopristin Sensitive
15008481 1/3/15 9:00 AM BLOOD Staphylococcus aureus rifampin Resistant
15008481 1/3/15 9:00 AM BLOOD Staphylococcus aureus trimethoprim/sulfamethoxazole Sensitive
15008481 1/3/15 9:00 AM BLOOD Staphylococcus aureus vancomycin Sensitive
15008481 7/3/15 9:00 AM bronchial secretions Klebsiella pneumoniae amikacin Resistant
15008481 7/3/15 9:00 AM bronchial secretions Klebsiella pneumoniae cefepime Sensitive
15008481 7/3/15 9:00 AM bronchial secretions Klebsiella pneumoniae cefotaxime Sensitive
15008481 7/3/15 9:00 AM bronchial secretions Klebsiella pneumoniae ceftazidime Sensitive
15008481 7/3/15 9:00 AM bronchial secretions Klebsiella pneumoniae ceftriaxone Resistant
15008481 7/3/15 9:00 AM bronchial secretions Klebsiella pneumoniae ciprofloxacin Sensitive
15008481 7/3/15 9:00 AM bronchial secretions Klebsiella pneumoniae imipenem Sensitive
15008481 7/3/15 9:00 AM bronchial secretions Klebsiella pneumoniae levofloxacin Sensitive
15008481 7/3/15 9:00 AM bronchial secretions Klebsiella pneumoniae meropenem Sensitive
(..) (..) (..) (..) (..) (..)
EpisodeID TimeStamp Type of Sample MicroorganismClass MultiDrug Resistant-Pathogen
15008481 1/3/15 9:00 AM BLOOD Staphylococcus aureus YES/NO
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Table 5: Illustrative Table of how Vital Signs are stored in hospital operational systems 
Drugs Administered: Each patient usually has several row entries in the drugs 
administered table for each timestamp. This occurs because a combination of drugs is given 
to the patient at specific timeframes during the day. The table records the drug ID that was 
administered to the patient, the corresponding episode (visit) and an administered date and 
time. 
 
Table 6: Illustrative Table of how Drugs administered are stored in hospital operational systems 
Each database also contains a series of descriptive tables that extend the information given 
by each ID (DrugID, ProcedureID, VitalSignID, among others). For the sake of simplicity, 
we did not expose those tables in this thesis but they were combined with the original tables 
to capture other related interesting variables. In some cases, those additional variables were 
used instead of the additional variable. 
EpisodeID VitalSignType TimeStamp VitalSignValue
15008481 Heart Rate 1/3/15 9:00 AM 65.0
15008481 Heart Rate 1/3/15 3:00 PM 59.0
15008481 Heart Rate 1/3/15 9:00 PM 90.0
15008481 Systolic Blood Pressure 1/3/15 9:00 AM 126.0
15008481 Systolic Blood Pressure 1/3/15 3:00 PM 118.0
15008481 Systolic Blood Pressure 1/3/15 9:00 PM 101.0
15008481 Temperature 1/3/15 9:00 AM 36.0
15008481 Temperature 1/3/15 3:00 PM NULL
15008481 Temperature 1/3/15 9:00 PM 36.0
(..) (..) (..) (..)
EpisodeID DrugID TimeStamp
15008481 A2333 1/3/15 9:00 AM
15008481 A4343 1/3/15 9:00 AM
15008481 A9775 1/3/15 9:00 AM
15008481 A3294 1/3/15 9:00 AM
15008481 A76775 2/3/15 9:00 AM
15008329 A2333 2/3/15 9:00 AM
15008329 A9775 2/3/15 9:00 AM
(..) (..) (..)
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Patient Demographics 
The demographic data used for each patient was the typical data that can be found in a 
Customer Relationship Management (CRM) system, such as age, gender or address. We 
also added some clinical variables to each patient, related to previous visits to the hospital; 
for instance, if the patient was at the hospital in the previous 30 days before the current 
episode. These variables, that can be available at the time of prediction, are very important 
because they would give us an approximation to the clinical severity and comorbidities of 
each patient, since the day 1 of our predictions (“patients that go several times to the 
hospital, tend to have an increased number of comorbidities”). These variables were 
codified as binary variables (flags), with 1 stating the patient had the event, and 0 stating 
otherwise. 
 
Table 7: Illustrative Table with Patient Demographics and additional calculated variables for each 
episode 
Patient visits (episodes) and Transfers among Clinical Departments 
For each hospital admission we have timestamped data about the patient physical location 
within the hospital. Physical Locations were collected at the Department level. Table 8 
shows how we can trace a patient's path through the hospital using the timestamped 
location data. By having this detailed information we can infer statistics about the local 
susceptibility to microorganisms of each department, at the time when the patient was 
physically allocated to that department, and we can also know when the patient was 
transferred to other department (for instance, an Intensive Care Unit). Each row in the 
Patient Transfers table reveals how long the patient stayed in each clinical department, and 
when he was transferred to other departments. 
EpisodeID Age Sex
Date of 
Admission
Has been in the 
Hospital in the past 
30 days since last 
visit?
Has caught a 
MDR Bacteria, 
in any episode, 
for the past 90 
days since last 
visit?
Has done 
surgery  in any 
episode, for 
the past 90 
days since last 
visit?
Has done 
chemoteraphy 
in any episode, 
for the past 90 
days, since last 
visit?
Has done 
hemodialysis in any 
episode, for the past 
90 days, since last 
visit?
Other calculated 
variables about the 
Episode
Has been in the 
Hospital in the last 
30 days?
15008481 89 Male 1/3/15 9:00 AM 0 1 0 0 0 1 0
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Table 8: Illustrative Table with the information contained in the EMR that allows us to follow a 
patient's physical trajectory through the hospital as he/she moves from department to department 
Decisions & Assumptions taken while Collecting and Correlating Data 
Timestamps and Data Granularity: As previously mentioned, this work involved 
correlating more than 100 different relational tables. These tables relate to different events 
and have different levels of data granularity (episode, day, period of inpatient visit and 
several others). Some events are registered several times a day and each table would have 
one line per each date and hour event (e.g. vital signs); other events occur randomly in 
time, for instance medications can be taken once a day, twice a day, ten times a day, once a 
week - it clearly depends on each clinical case. As in lab results, they also have a random 
behavior depending on the case complexity; they can be requested only once a week, but 
sometimes they might be requested several times a day. This means that each table would 
have different granularities in terms of the data.  
In this work we hypothesized that, while joining all the tables, we had to define a 
timestamp in order to locate each lab result, medication taken or vital sign measured, 
according to each inpatient day, collecting all the tables by the episode ID key. Therefore, 
as the dataset would have the granularity of the inpatient day (day 1, day 2,…day n of 
inpatient episode), we had to choose a specific hour in each inpatient day to combine with 
all the tables (lab results, medications, vitals) that were at a lower level of granularity 
(episode ID, timestamp, measured value), as these tables could have several registries, for 
each patient, in each inpatient day. 
The specific timestamp chosen to join all the tables was 1 minute to midnight in each day 
(23h:59 min). The idea was to choose a timestamp that would replicate and simulate a 
timestamp in which this algorithm would run when used in a real-world scenario. We 
TransferID EpisodeID TimeStamp of Entrance TimeStamp of Exit Clinical Department
Surgery? 
(yes/no)
Other 
variables 
about the 
Clinical 
Department
23032 15008481 20/2/15 6:00 PM 1/3/15 9:00 AM Ortopedics 1 (..)
23033 15008481 1/3/15 9:00 AM 5/3/15 8:00 PM Internal Medicine 0 (..)
23034 15008481 5/3/15 8:00 PM 10/3/15 11:00 AM Intensive Care Unit 0 (..)
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hypothesized that the algorithm would run at this specific hour, in each inpatient day. This 
decision was carefully thought and was not chosen by luck. Some of the reasons that 
sustained this decision were: 
1. Different areas inside the Hospital work at different rhythms and physicians can 
also be included in this reality. This means that lab results might get released in 
the early morning, the drug prescribed might only me administered after lunch 
and some vital sign might only be measured late afternoon. At the end of the 
day, all the major clinical activities about the patient have been fulfilled. This 
means that this is the best time to obtain the most complete picture about the 
patient clinical state; 
2. At the end of the day, all the drugs that have been prescribed to the patient are 
stored in the database and, therefore, we could benefit from having this 
information. If the model was scheduled to run during the day we could lose an 
important number of drugs prescribed immediately after running the algorithm; 
3. Moreover, clinically speaking, we can assume that each inpatient day starts at 
midnight. This also has a significant meaning, because until midnight a lot of 
events can still happen; 
4. Midnight is the most probable hour to have less activity in terms of meaningful 
clinical related events. This is because patients are usually taking some drug at 
this time and are supposed to be asleep; 
5. Finally, the clinical staff inside the hospital at this time is the minimum and, 
therefore, no much activity is registered. 
Variable Granularity – Avoiding Overfitting and Controlling Dimensionality 
As previously exposed, besides the illustrative data tables that were shown for each type of 
variable (vital signs, lab results, drugs administered), each database also contains a series of 
descriptive tables that extend the information given by each ID (DrugID, ProcedureID, 
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VitalSignID). The descriptive information contained on those tables, after being combined 
with each corresponding ID, extends the number of possible variables to use for the model. 
On the other hand, it can also bring new variables to replace the original IDs. 
A good example of this is related to the Drugs administered. The main table related to the 
drugs administered in the operational system had the DrugID field in it, but, if we were to 
use this field in the model, two problems could occur: 
 The model capability to generalize would decrease, while its risk of overfitting 
would increase, because the DrugID is too specific and detailed in order to detect 
general patterns; 
 The dimensionality of the problem would become unfeasible. There are thousands 
of DrugIDs considering that each drug can have different formulations. As this 
work intends to measure the number of cumulative and consecutive days that the 
patient is taking each drug in each inpatient, taking all the DrugIDs as variables 
would mean that the model would have more than 5000 different variables just to 
account for the different DrugIDs. The “curse of dimensionality” is the biggest 
problem in ML after overfitting, because generalizing correctly becomes 
exponentially harder as the dimensionality of training examples grows (Domingos, 
2012). 
In the final model, instead of using the variable that demonstrated the specific and very 
detailed drug (DrugID) that was administered to the patient, the Pharmacotherapeutic group 
of that drug was used instead. This same reasoning was used in several other areas, for the 
reasons already explained. This approach also has disadvantages. While we used a higher 
level in the Drugs hierarchy to build the drugs related variables, we also lose some drug 
details that might be important for the practice model. For instance, in some specific 
bacteria, it might not be enough to know if the patient is taking antibacterial drugs, because 
the microorganisms only react to some specific types of antibacterial drugs. 
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3.2 QUICK EXPLORATORY DATA ANALYSIS 
As this dataset is a highly dimensional dataset with more than 1000 variables (1225 
features before feature engineering) it is impossible to start exploring each variable 
individually. Therefore, the first thing we opted to do was to use the capabilities of Excel 
pivot tables and conditional formatting to explore the dataset, in order to get a sense of the 
occurrence of each of the columns we were trying to predict (outcome variables), and to 
observe their prevalence. We did all the statistics by separating the results for each 
biological location of the Microbiological Results we were trying to predict (blood, urine, 
bronchial secretions) since we knew this would make more sense for clinicians. These 
statistics were calculated to have a perspective of the number of first isolates of each type 
of Bacteria. 
The next figure shows clearly that Enterobacteriaceae ESBL+ is a common MDR bacteria 
among infected patients, followed by Enterobacteriaceae XDR and the MRSA bacteria, for 
all biological locations (blood, urine, bronchial).  
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Figure 10: Example of how DrugIDs were grouped into Pharmacotherapeutic groups 
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Figure 11: Exploratory Data Analysis of the most common infections grouped by MDR 
bacteria 
Following the same reasoning and using the power of conditional formatting functionality 
of Excel, we realized that some of these MDR bacteria tend to occur more in specific parts 
of the body (biological location). For instance, Tuberculosis infections clearly occur on 
bronchial secretions while infections caused by Enterobacteriaceae XDR tend to occur 
more in Urine and MRSA infections are also more common in bronchial secretions. 
 
Figure 12: Exploratory Data Analysis of MDR bacteria occurrence in each of the Body 
Locations 
As we started looking into each of these outcome variables (different types of MDR 
bacteria), grouped by the biological product where these bacteria were detected, we realized 
that it would make more sense to split the initial dataset into three separate datasets (one for 
Distinct Count of 1st Isolated Cases .
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"Alert" type MDR Microorganism 271 143 73 89
Acinetobacter spp Carbapenemos Resistente 9 19 3 4
Enterobacteriaceae Carbapenemos Resistente 21 13 9 17
Enterobacteriaceae ESBL + 185 90 49 60
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Enterococcus faecium Vancomicina Resistente 43 10 3
St.aureus Daptomicina Resistente 1
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St. aureus Meticilina Resistente 24 116 27 81
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each biological product) and to develop a different predictive model for each one of them, 
as figure 13 demonstrates. 
 
 
The decision of splitting the initial dataset into different datasets, according to the 
biological product of the microbiological lab results, also took into account the feedbacks 
received from the initial Business Problem Understanding and the interviews that were 
conducted with the clinicians (Chapter 2). From those interviews, it became clear that they 
think and act differently upon infections located in different parts of the body. Although we 
trained different algorithms for each of these three datasets, the major tasks of 
preprocessing steps were accomplished using the initial dataset, as it would be timely 
unfeasible to do it for each dataset. 
3.3 DATA PROBLEMS & REDEFINITION OF THE BUSINESS PROBLEM 
Severe Data Problem Related to Case Definition  
After a quick exploration of the Data, particularly of each of the outcome columns (each of 
the MDR bacteria we were trying to predict for each biological product), we immediately 
realized that there were two important findings: 
Initial Dataset 
(Patients with 
Blood, Urine or 
Bronchial Lab 
Results)
Dataset 3 - Patients 
with Bronchial Lab 
Results
Dataset 2 -
Patients with 
Urine Lab 
Results
Dataset 1 - Patients 
with Blood Lab 
Results
Figure 13: Illustrative Diagram of how the Initial Dataset for this work was Split in three different 
datasets 
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1. All the outcome variables were highly unbalanced, with a few number of positive 
cases; 
2. The balancing of all the outcome variables, even in different biological products, 
was very similar (1000 negative cases). 
 
Figure 14: Histogram illustrating the Balance of Positive and Negative Cases for each MDR 
bacteria in blood samples 
 
Figure 15: Histogram illustrating the Balance of Positive and Negative Cases for each MDR 
bacteria in respiratory samples 
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Figure 16: Histogram illustrating the Balance of Positive and Negative Cases for each MDR 
bacteria in urine samples 
Regarding finding number one, we assumed that the low number of positive cases was 
related with the complexity of the initial objective of this work: “finding if the isolation of a 
bacteria in the next 72 hours would be a HAI MDR bacteria”. As we were only classifying 
the microbiological lab result which contained the first isolate as a “Positive Case”, few 
cases would appear as positive. This also meant an increasing complexity to define positive 
and negative cases, as positive cases cannot be positive again after the first time they 
appeared. 
Regarding finding number two, this brief exploration of the Data led us to conclude that 
something needed to be wrong with the data collected, because different biological 
products should reveal different balancing degrees related to the outcome classes. For 
instance, in clinical practice, clinicians request for more urine samples than blood samples; 
therefore, the number of samples in Urine and Blood should be different, which was not the 
case.  
After reviewing the SQL scripts that extracted the data from the hospital Data Warehouse, 
we realized that cases were not being correctly classified. Those scripts were not taking into 
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account negative lab results, were there were no MDR bacteria in the specific biological 
product for which the lab analysis was requested. That said, the script was not taking into 
account negative lab results, were there were no MDR bacteria in the specific biological 
product for which the lab analysis was requested. Therefore, different lab results, from 
different biological products, were influencing each other, and reducing the number of 
negative cases in each biological product, which was not acceptable. The SQL script was 
corrected, all the data was extracted again, and the outcome class balance for this new 
dataset would be quite different for each biological product, which reveals that our initial 
suspect of corrupted data was correct. 
Redefining the Business Problem – New Data Extraction 
In the previous point, while doing a quick Exploratory Data Analysis, we realized that there 
were few positive cases, with less than 20 positive cases in some types of MDR bacteria in 
a population that could exceed 1000 negative cases. Besides, as explained in the previous 
point, only using the first isolate of each MDR bacteria detected as a “Positive Case”, it 
would not only maintain this low number of positive cases, but also increase the 
challenging of classifying positive and negative cases in the dataset. Therefore, with the 
great suggestion of my supervisor, Professor João Gama, we decided to simplify the 
Business problem: “Detect if, in the next 72 hours, the patient might have a positive result 
for any HAI MDR bacteria”. This change in the Business Problem meant that we would not 
be interested in detecting the specific type of MDR bacteria found, as initially planned. 
Instead, we would be interested if any of these MDR bacteria appeared in a microbiological 
result (in the 72 hours after the date index), classifying these cases as positive (infected). If 
all the microbiological lab results in that period turn out to be negative, we would classify 
those cases as negative. This subtle change in the Business Problem meant that we had to 
aggregate all the positive lab results for each MDR bacteria, in a new calculated column, as 
figure 17 illustrates: 
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In the aggregation process of all the outcome columns (different HAI MDR bacteria types) 
into a single calculated column, we were careful to do this process, separately, for each 
biological product. Therefore, as figure 18 demonstrates, the final dataset used for 
modelling had three outcome columns - one for each biological product - which we called 
“MDRXDRBLOOD”, “MDRXDRURINE” and “MDRXDRBRONCHIAL”, in reference 
to the location where the HAI MDR bacteria initially appeared (microbiological lab result). 
As we had to build a predictive model for each of these different outcomes, we separated 
the dataset into three different datasets, as figure 18 illustrates. 
 
Figure 18: Illustrative Diagram of the tree final Datasets used in the predictive modelling phase, 
with a single aggregated outcome column 
Figure 17: Illustrative Diagram of how the new calculated columns for the outcome were built 
Aggregated Outcome 
Variable 
("MDRXDRBLOOD
")
MDR bacteria 
Type 1
MDR bacteria 
Type 2
MDR bacteria 
Type n
MDR bacteria 
Type 17
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3.4 FURTHER EXPLORATORY DATA ANALYSIS 
As previously mentioned, this work involved thousands of variables. In an ideal world, it 
would make sense to explore each of the predictor variables used and look for Exploratory 
Data Analysis usual findings, such as the searching for kurtosis, skewness, and outliers in 
each variable. However, given the number of variables in this problem and the short time 
left to conclude it, we needed to use a Machine Learning and Big Data approach, ignoring 
most of the Data Analysis work and investing more effort in using some common 
techniques to treat variables (scaling, standardizing, removing zero variance variables, 
among others) in the feature engineering step, with the focus on performance.  
We decided not to invest time looking at the properties of individual features by analyzing 
univariate attribute distributions. Therefore, our bet was in searching for patterns in 
combinations of attributes among features chosen randomly from the major groups of 
variables that characterize our dataset (figure 19). 
 
Figure 19: Illustrative Diagram of the major groups of predictors involved in this work’s dataset 
The Software Waikato Environment for Knowledge Analysis (WEKA) provides one of the 
most powerful scatter plot visualizations that allows us to review the pairwise relationships 
between attributes. This is very useful as it can highlight any patterns in the relationship 
between the attributes, such as positive or negative correlations. The dots in the scatter 
plots can be colored by their class value of interest, in this case, infected or not infected. 
We used this functionality of WEKA because we had thousands of variables and the 
WEKA Visualize tab allows to build an intuitive scatter plot with all these variables, in a 
matter of seconds, as figure 20 demonstrates. 
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Figure 20: Illustrative Diagram WEKA’s scatter plot functionality (Visualize Tab) 
Our main interest with these scatter plots functionality was to be able to quickly look for 
trends or patterns in the thousands of variables involved in this work, by observing how the 
dots (cases) were distributed and correlated, looking for interactions that could represent a 
clear separation of the colors. WEKA allowed us to adjust the resolution of these plots, 
increasing the size of the plots, the size of the dots and adding “jitter”, in order to observe 
the maximum number of possible variables in an easy way. Particularly, jitter functionality 
will add some random noise to the data in the plots and spread out the points a bit, which 
will help us to see what is going on. We found that using PlotSize=190 and PointSize=8 
parameters would represent the best visualization for this dataset. 
Having in mind the thousands of variables and the time restrictions involved, our strategy 
to explore the dataset variables was to select random groups of variables among each of the 
major types of variable groups previously demonstrated in the diagram of figure 19. By 
selecting random groups of features we reduced the bias and increase the probability of 
finding useful patterns. 
After repeating, for several times, the work of selecting random variables among each 
group of variables and finding if interesting patterns could be found by visually exploring 
the plots, we gathered the most interesting patterns which will be explained in the following 
points. 
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In the following plots, infected patients with HAI MDR bacteria in the next 72 hours are 
signed with blue colored dots. Patients which had a negative result for HAI MDR bacteria 
in the next 72 hours are signed with red colored dots. 
Older patients, that stay longer in the hospital, seem to get more infections caused by HAI 
MDR bacteria 
In the following plot, the number of days in the hospital is plotted in the X Axis, alongside 
with the patient age, which is plotted in the Y Axis. 
 
Figure 21: Number of days in the hospital (X Axis) plotted against patient age (Y Axis) 
It is clear that, as we approach the right side of the graph, we have more infected patients 
(blue points). This reveals that patients that stay longer in the hospital (variable “DX” 
represents number of days in the hospital) get more HAI MDR bacteria. At the same time, 
although less expressive, it also seems that the blue cases (infected patients) seem to be 
more predominant in the upper right corner of the graph. This might be an indication that 
older patients have more infections than younger ones, especially when they stay longer in 
the hospital. 
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In most clinical departments, as the number of hours elapsed since the admission in the 
department increases, more cases of patients with an infection caused by a HAI MDR 
bacteria seem to appear 
In the following plot, a flag signaling if the patient is hospitalized in a specific Department 
is plotted in the X Axis, alongside with the hours elapsed since the admission in the current 
clinical department, which is plotted in the Y Axis. 
 
Figure 22: Several scatter plot graphics. Each graphic has these variables plotted: (0/1) Flag 
signaling if the patient is hospitalized in a specific Department (X Axis) plotted against hours 
elapsed since the admission in the current clinical department (Y Axis) 
The plot demonstrates that the number of hours since the patient entered the clinical 
department is correlated with the number of patients that have a HAI MDR bacteria, for 
almost all departments. 
Although this pattern seems to happen in the majority of departments, we found out that a 
specific department had a very particular and interesting pattern; this department was the 
“Burns Unit”.  
In the Burns Unit department, the proportion of patients with infections caused by a HAI 
MDR bacteria is very high when compared with all other departments. Besides, these 
infections appear in the first hours elapsed since the admission in the department 
In the following plot exposed in figure 23, a 0/1 flag signaling if the patient is hospitalized 
in the Burns Unit Department is plotted in the X Axis, alongside with the hours elapsed 
since the admission in the current clinical department, which is plotted in the Y Axis. 
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Figure 23: (0/1) Flag signaling if the patient is hospitalized in the Burns Unit Department (X Axis) 
plotted against hours elapsed since the patient entered the department (Y Axis) 
By looking at the plot exposed in figure 23, we observe that the Burns Unit Department has 
a very distinct behavior when compared to other Departments. In the right side of the X 
axis we have the patients that were hospitalized at the Burns Unit department (variable 
“SERVRESP_UnidadeQueimados” is equal to “1” when the patient was hospitalized at the 
Burns Unit Department and “0”, when otherwise), and, on the left side of the graph, we 
have the patients that were hospitalized in every other clinical department.  
It is very clear that we have much more prevalence of blue dots in the right side of the 
graph when compared with the left side of the graph. This reveals that patients who were 
hospitalized in the Burns Unit tend to have more infections caused by HAI MDR bacteria 
than all the other patients hospitalized in other clinical departments. Simultaneously, we 
observe that in this department, even patients that have few hours of hospitalization in the 
department, have HAI MDR bacteria (lower right corner of the plot). This contradicts what 
was initially stated for most of the clinical departments: that more hours in the clinical 
department represent more patients infected with HAI MDR bacteria. This probably means 
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that patients that are staying in the Burns Unit are more vulnerable and, therefore, can be 
easily infected in the first few hours of hospitalization. 
Patients with lower values in the first measurement of Hemoglobin in the last 36 hours, 
seem to get more infections, and this seems to increase if their standard deviation from 
average patients also increases in their Systolic Blood Pressure measured in the last 
24hours 
In the following plot, the First Measurement of Hemoglobin in the last 36 hours is plotted 
in the X Axis, alongside with the Standard Deviation (from the population average) of 
Systolic Blood Pressure measured in the last 24 hours, which is plotted in the Y Axis. 
 
Figure 24: First Measurement of Hemoglobin in the last 36 hours (X Axis) plotted against Standard 
Deviation of Systolic Blood Pressure in the last 24 hours 
As we approach the left side of the plot, we have more cases of infected patients (blue 
points), revealing that patients with a low hemoglobin value measured in the last 36h 
(variable “PRIMEIRA36H_CAT3” represents the first hemoglobin value measured in the 
last 36 hours, from the index date) are correlated with patients with a HAI MDR bacteria in 
the following 72 hours. Patients with lower levels of hemoglobin are usually at high risk of 
death and some clinical studies already stated that low levels of hemoglobin predisposes to 
acute bacterial infection (Musher et al., 2004).  
Although less expressive, the plot also reveals that blue cases (infected patients) are more 
predominant in the upper left corner of the graph. This shows that patients with high values 
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in the Standard Deviation (from the population average) of their Systolic Blood Pressure 
measured in the last 24hours (variable “STDEV_24H_CAT12”), are correlated with 
patients that had a HAI MDR bacteria in the following 72 hours. In clinical practice, 
Systolic Blood Pressure level is positively associated with Hemoglobin level. 
Patients with excessive number of cumulative days on anti-infectious drugs for the skin and 
reduced number of consecutive days on Genitourinary dysregulation drugs (or Vice-Versa), 
seem to get more infections caused by HAI MDR bacteria 
In the following plot, the cumulative days on Anti-infectious drugs for the skin are plotted 
in the X Axis, alongside with the consecutive days on genitourinary dysregulation drugs, 
which is plotted in the Y Axis. 
 
Figure 25: Cumulative days on Anti-infectious drugs for the skin (X Axis) plotted against 
consecutive days on genitourinary dysregulation drugs 
The plot reveals two distinct patterns. The first pattern is that patients with an excessive 
number of cumulative days on Anti-infectious drugs for the skin that also have a reduced 
number of consecutive days on genitourinary dysregulation drugs, have more infections 
with HAI MDR bacteria in the following 72 hours. The second pattern is that patients with 
an excessive number of consecutive days on genitourinary dysregulation drugs that also 
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have a reduced number of cumulative days on Anti-infectious drugs have more infections 
with HAI MDR bacteria in the following 72 hours. 
Patients with an excessive number of consecutive days on thyroid gland drugs or 
Genitourinary dysregulation drugs, or patients with an excessive number of cumulative 
days on anti-anemic drugs, seem to get more infections caused by HAI MDR bacteria 
In the following three plots, the number of consecutive days on thyroid gland drugs (first 
plot), the number of consecutive days on genitourinary dysregulation drugs (second plot) 
and the number of cumulative days on anti-anemic drugs (third plot) is plotted in the X 
Axis of each plot, alongside with other variables plotted in the Y Axis. 
 
 
 
Figure 26: Random variables chosen from the dataset (X Axis) plotted against the number of 
consecutive days on thyroid gland drugs (first plot), number of consecutive days on Genitourinary 
dysregulation drugs (second plot) and the number of cumulative days on anti-anemic drugs (third 
plot) (Y Axis) 
These three plots demonstrate that, no matter the variable we plot on the X Axis, an 
excessive number of consecutive days on thyroid gland drugs (first plot) or an excessive 
number of consecutive days on genitourinary dysregulation drugs (second plot) or even an 
excessive number of cumulative days on anti-anemic drugs (third plot) are positively 
correlated with patients that had a HAI MDR bacteria in the following 72 hours. This 
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pattern is clear in the three plots, as the number of blue dots (infected patients) is 
predominant when any of these three types of drugs are taken for a long number of days. 
Patients with an excessive number of cumulative days on anti-thrombotic and vasodilatory 
drugs which, simultaneously, have an excessive number of cumulative days on narcotic 
drugs, seem to get more infections caused by HAI MDR bacteria 
The following plot shows the number of cumulative days on anti-thrombotic and 
vasodilatory drugs, which is plotted in the X Axis, alongside with the number of 
cumulative days on narcotic drugs, which is plotted in the Y Axis. 
 
Figure 27: Cumulative days on anti-thrombotic drugs (X Axis) plotted against Cumulative days on 
anti-thrombotic drugs (Y Axis) 
The plot demonstrates that, for some patients, there is a positive correlation between the 
number of cumulative days on anti-thrombotic and vasodilatory drugs and the number of 
cumulative days on narcotic drugs. The plot also demonstrates that, patients where this 
positive correlation occurs usually have a HAI MDR bacteria in the following 72 hours, as 
blue dots are predominant when the patient is with an excessive number of cumulative days 
with both types of drugs. 
When the Susceptibility of Enterobacter Bacteria to gentamycin antibiotic is low in the 
entire hospital and the local Susceptibility of Enterococcus Faecium Bacteria to 
Daptomycin antibiotic is high, patients seem to get more infections caused by HAI MDR 
bacteria 
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In the following plot, the Local Susceptibility of Enterococcus Faecium Bacteria to 
Daptomycin antibiotic is plotted in the X Axis, alongside with the Hospital Susceptibility 
of Enterobacter Bacteria to Gentamycin antibiotic, which is plotted in the Y Axis. 
 
Figure 28: Local Susceptibility of Enterococcus Faecium Bacteria to Daptomycin antibiotic 
(X Axis) plotted against Hospital Susceptibility of Enterobacter Bacteria to Gentamycin 
antibiotic (Y Axis) 
The right lower side of the graph is clearly dominated by blue dots (infected patients) when 
compared to other areas of the graph. This clearly demonstrates that, when the Hospital 
Susceptibility of Enterobacter Bacteria to gentamycin antibiotic is low (Y Axis) and the 
local Susceptibility of Enterococcus Faecium Bacteria to Daptomycin antibiotic is high (X 
Axis), patients seem to get more infections caused by HAI MDR bacteria. 
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4. DATA PREPARATION (FEATURE ENGINEERING) 
The features used in a model are the most important factor for a ML project to succeed. 
Typically, most of the effort in a ML project goes to feature engineering (Domingos, 2012). 
In fact, the tasks related to data gathering, integration, cleaning and pre-processing, as well 
as all the associated trial and error that comes along, were the most time consuming tasks of 
this work. This is a mixture of Data Understanding and Feature Engineering. As figure 29 
demonstrates, the relative effort in these steps, when compared with other steps in this 
work, were clearly the most time consuming. 
 
Figure 29: Data Science Process used in this Work (Relative Time Lost in each Step) 
4.1 CREATING NEW CALCULATED VARIABLES FROM EXISTING ONES 
One of the methodologies we applied in the Feature Engineering phase was to generate new 
variables from existing raw data we already had. The reasoning behind this decision is that 
we can extract new meaningful predictors just by applying some calculations over the time 
series of raw attributes initially extracted (e.g. average, standard deviation from average, 
first value measured in the last 24 hours, minimum value measured in the last 36 hours, 
maximum in the last 48 hours, among others).  
The decision to create new calculated variables from existing ones was taken in three areas 
which represent important measurements to assess the clinical risk of each patient 
throughout the time: Vital Signs, Biochemical Lab Results and Microbiological Lab 
Results. 
Vitals & Biochemical Lab Results 
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When extracting information about vitals and laboratory results for each patient, we tried to 
encode these results into 17 different categories. These categories are exposed in table 2: 
 
Table 9: Types of Vitals and Lab Results Categories used in the Predictive Model 
For each Category Type of Vital Signs and Lab Results, we built a global script that was 
able to apply a series of calculations to each of these categories, and generate new variables 
from each measured value and associated timestamp in each category. The idea of this 
approach was to be able to build a series of new features from the original ones, because 
this process can sometimes capture the important information in a dataset much more 
effectively than by only using the original features. For each attribute, of each category 
type, we generated 32 new calculated columns. This reasoning is represented in figure 30. 
Category Type Category
1 Creatinine
2 Glicemia Capilar
3 Haemoglobine
4 White Blood Cells (WBC)
5 Platelets
6 Potassium
7 Sodium
9 International Normalized Ratio (Anticoagulation)
10 Temperature
11 Heart Rate
12 Systolic Blood Pressure
13 Activated Partial Thromboplastin TimE (aPTT)
14 Glucose
15 C Reactive Protein
16 Respiratory Rate
17 O2 (Oxigen Saturation)
18 Level of Consciousness 
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Figure 30: Diagram illustrating how we obtained 32 new calculated variables from each lab result 
and vital sign 
 
After creating the new calculated attributes we added 544 new attributes to our dataset. 
Susceptibility Patterns obtained from Microbiological Lab Results: 
It is well established that the resistance profile of each infectious agent to each antibiotic, as 
well as the exposure of each patient to these agents, is the key factor that leads physicians 
to choose the right antibiotic for each patient (Abel et al., 2014; Leibovici et al., 1999). To 
emphasize the importance of this subject, the work of Jenna Wiens on Learning to Prevent 
Healthcare-Associated Infections with ML (Wiens, 2014) mentions the creation of a 
“colonization pressure” predictor variable. This variable was a complex calculation that 
tried to aggregate the amount of time each patient was in exposed to other infected patients, 
in order to better assess the risk of becoming infected later.  
In this work we had the opportunity to generate calculated variables that could help us 
assess the prior risk of the patient being infected. By applying all the computer power over 
thousands of microbiological lab results data, we managed to easily obtain aggregated 
statistics about the susceptibility patterns of each infectious agent to each antibiotic, in the 
previous 90 days of date index. These statistics were separated in two groups of variables:  
Blood Pressure 
value at 9 a.m
First Measurement 
in the last 7days
First Measurement 
in the last 48 
Hours
First Measurement 
in the last 36 
Hours
First Measurement 
in the last 24 
Hours
(..)
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 Group 1: Variables that represent the Local Susceptibility Rate of each Infectious 
Agent to each Antibiotic. These variables were created with the “R_” initials, to 
refer to “local resistance”. For instance, a variable named “R_Staphylococcus 
aureus Daptomycin” was created for each case. This variable returns the local 
susceptibility rate of all patients with Staphylococcus Aureus positive results that 
were tested against the Daptomycine antibiotic, in the previous 90 days of date 
index; 
 Group 2: Variables that represent the Hospital Susceptibility Rate of each 
Infectious Agent to each antibiotic. These variables were created with the “RHSJ” 
initials, to refer to “all Hospital resistance”. For instance, a variable named 
“RHSJ_Staphylococcus aureus Daptomycin” was created for each case. This 
variable returns the susceptibility rate of all patients inside the hospital with 
Staphylococcus Aureus positive results that were tested against the Daptomycine 
antibiotic, in the previous 90 days of date index. 
After creating these new calculated attributes we added 534 new attributes to our dataset. 
4.2 FEATURE TRANSFORMATION 
Automated & Systematic Machine Learning Methodology 
The pre-processing phase of this work was the most demanding and time consuming phase. 
The large dimensionality of the dataset used in this work, with more than 1000 variables, 
required a systematic and data driven approach to be able to pre-process several variables in 
parallel by applying only one command line of code. This ability to automate these feature 
engineering processes is one of the holy grails of using a machine learning approach 
(Domingos, 2012). 
Given the excessive number of variables we had to transform in the feature engineering 
process, and our desire to build an automated system, using R was the most adequate 
solution and methodology. For that, we developed an extensive R script that was able to 
apply different types of treatment to a significant number of variables, in sequential 
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manner. In figure A.1 of Appendix 2, all the R code related to the systematic 
implementation of all Feature Engineering tasks is available, along with a detailed 
explanation of each step. 
Many types of algorithms are very sensitive to the type of data that is given to them, and 
require the data to be in a specific form. Our vision for this work was to apply the 
maximum number of transformations to the dataset, in order to obtain a data structure that 
could be interpreted by several types of algorithms. 
All the extensive pre-processing work that was performed in this stage can be resumed into 
the following tasks: 
 One-hot encoding of categorical variables; 
 Box-Cox Transformation; 
 Standardization; 
 Remove irrelevant features due to NULL values; 
 Remove Zero-Variance Variables; 
 Replace missing values. 
The tasks mentioned above represent a combination of transformations that were applied to 
the data, using an automated approach (R script), and will be detailed in the following 
points. 
Feature Engineering Tasks 
Most of the feature engineering tasks in this work were accomplished in an automated 
fashion, using the R Caret Package. 
Standardizing the data 
The result of standardization procedures (or Z-score normalization) is that the features will 
be rescaled so that they will have the properties of a standard normal distribution with μ=0 
and σ=1, where μ is the mean (average) and σ is the standard deviation from the mean.  
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This process is particularly important if we are comparing measurements that have different 
units, but it is also a general requirement for many machine learning algorithms. 
In the R Caret package, the process of standardization of the data occurs by combining the 
scale and center transformations to the data.  
The center transformation calculates the mean for an attribute and subtracts it from each 
value. The scale transformation calculates the standard deviation for an attribute and 
divides each value by that standard deviation. 
After applying the “scale” and “center” methods of the “preProcess ()” function in the R 
Caret package to our training dataset, 1153 variables were standardized.   
 
Figure 31: Figure illustrating the results of the transform function (R Caret package) after 
standardizing our dataset 
The test set was standardized with the statistics obtained in the training set. 
Box-Cox transformation 
Box-Cox transformations area a useful solution when we want to approximate each 
attribute in the dataset to a normal distribution. Many ML algorithms assume that all 
attributes have this property from the very beginning, which usually does not happen to be 
true. While there are different transformations (e.g., square root, log, inverse) that can be 
applied to the data for improving normality, the Box-Cox transformation represents a 
family of power transformations that are a best-practice for normalizing each variable 
(Osborne, 2010). 
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To help reduce the skewness of the attributes in our dataset and make them more Gaussian, 
we applied the Box-Cox transformation to it. This was done by using the Box-Cox method 
of the “preProcess ()” function in the R Caret package. 
After applying the Box-Cox transformation to our dataset, 350 variables were automatically 
transformed, which reveals that our dataset had several variables that suffered from 
skewness. 
Removing irrelevant features due to NULL value columns 
We applied a series of commands to find out if there were any columns in the dataset that 
only had “NULL” values. These columns are not relevant for any classification model and, 
therefore, should be removed. We found 109 columns in this situation. These columns with 
NULL values were related with two situations: 
 Specific types of drugs that, although available in the hospital pharmacy, were not 
taken by any patient; therefore, all patients had a NULL value for this variable; 
 Specific types of bacteria susceptibility rates (bacteria and antibiotic combinations) 
where there was no growth of any bacteria of that type. Although this bacteria can 
appear in the future, as no case was tested, the susceptibility rate could not be 
calculated and returned NULL value for all cases. 
These columns were removed from the dataset and are detailed in table A.1 of Appendix 3. 
Removing irrelevant features due to zero variance 
We applied a series of commands to find out if there were any columns in the dataset with 
only one value. These columns are not relevant for any classification model and, therefore, 
should be removed.  
One of the columns in this condition (column named “Cateter_Venoso_Central_SaT_ 
Jugular”) was related to the presence or absence of a specific type of catheter in a patient. 
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This probably occurs because there is no patient with this kind of catheter registered in the 
system, or there is only one patient in the dataset, which is also meaningless.  
Besides, a significant number of other columns were also removed. These columns were 
mostly related with some specific kinds of drugs that few patients take, like “venotropic” 
drugs, and also with susceptibility rates of bacteria against antibiotics that are often not 
tested.  
The 169 columns removed from the dataset, after this work, are detailed in table A.2 of 
Appendix 3. 
Converting categorical to binary variables (one-hot encoding): 
This is one of the primary techniques to use in feature engineering when categorical 
variables exist in the dataset, being mentioned in the general tips for participating in Kaggle 
Competitions (Peng, 2015). 
One hot encoding methods transform each feature into a new set of binary (values 0 or 1) 
features for all its symbolic values. The methods are important when feeding categorical 
data to linear models and SVMs. Since we had original features that were discrete category 
value, we could not directly apply linear classifier models on this kind of data. Therefore, 
as we intended to test several types of models over our data, including linear models, we 
decided to do one-hot encoding over the categorical variables. This follows the systematic 
methodology of doing all the preprocessing at once, and then obtains a dataset that can be 
given to different types of algorithms. Besides, this strategy of using binary variables 
instead of the original categorical variables was also applied by the winner of the 3 million 
dollars health heritage machine learning prize (Brierley et al., 2013). 
That said, in this work, we applied one-hot encoding to 15 categorical variables (e.g. 
weekday). 
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Replacing missing values 
Healthcare Data is rarely clean and, often, we can encounter corrupt or missing values.  
Most of the corrupt values that could appear in our dataset had already been previously 
treated while importing data from the Hospital’s operational systems into the centralized 
Data Warehouse (DW). For instance, impossible values related with vital signs registries 
are immediately removed in this process. Therefore, we had to focus mostly on searching 
for missing values. 
By using the power of R and the “apply()” function, we were able to detect that hundreds of 
columns in the dataset had missing values. These columns where mostly related with vital 
signs or lab results features, and also with the susceptibility rates of several types of 
bacteria. Some heurist techniques to replace these missing values could have been applied 
to correct this problem, but the time needed to replace missing values with a dataset of this 
size would require significant computation power. Therefore, for the sake of time, we 
decided to apply the median of each these columns, to replace missing values in an 
automated fashion. We used the median value of all patients to do this for each of the 
columns (Gama et al., 2012). 
4.3 DATA SIZES & DATA FORMAT CHALLENGES 
This work involved a huge time investment in dealing with errors directly related with the 
size of our dataset, and also errors related with the data quality issues; both of these 
problems must not be neglected. 
Data Sizes Challenges 
Regarding the Data Sizes issues, it must be said that this dataset can easily be categorized 
as a “Big Data” dataset. Therefore, just to open the Comma Separated Value (CSV) data 
file, extracted from the DW, that contained the data for this problem, a laptop machine with 
SSD disks and 32 GB of RAM took 15 minutes. The CSV file used for this problem had a 
size of 6GB. 
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Along the course of this work we tried several methodologies and lost a significant amount 
of time in trying to find an agile way to open and explore in a faster way the data contained 
in these CSV files. We even tried some promising research tools as Google Refine, but the 
result was poor performance. 
 
Figure 32: Google Refine showing an estimate of 435 minutes to load the Dataset for this problem 
As figure 33 demonstrates, some simple operations, like removing a few columns in the 
dataset, could affect more than 20 million cells, which causes huge problems to Excel and 
gives an idea of the dimensionality of this data. 
 
Figure 33: Number of cells affected by removing five columns in the CSV Spreadsheet with the 
Data for this problem 
The solution to deal with all this dimensionality, in an agile fashion, was to produce new 
CSV files with a small number of cases taken from the original file, randomly. This 
allowed us to quickly explore the dataset and its columns datatypes and to start producing 
some R code to automate tasks over the dataset. After planning all the tasks to be 
performed, we applied those tasks to the original CSV file.  
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Data Format Challenges 
While Pre-Processing the dataset used in this work, we faced hundreds of different 
situations related to errors reported by R functions when dealing with specific types of 
columns. Often, the solution was to convert the datatype of the columns that were 
contributing to block the R function execution and transforming those columns to other 
datatypes. However, to understand the cause of these errors, and alter the code accordingly, 
weeks of working hours were spent. The figure below illustrates one of these examples.  
 
 
 
  
Figure 34: Example of the thousands of errors that we needed to debug in R throughout this work 
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5. MODELING & EXPERIMENTATION 
METHODOLOGY 
5.1 APPROACH TO THE BUSINESS PROBLEM - THE DATA DRIVEN APPROACH 
Modeling and Experimenting 
Having in mind the short time-frame for this research and the need to model and 
experiment Big Data datasets, the work involved to achieve good predictive models could 
be cumbersome and it could easily become something that would only be achievable in the 
3 years’ time-frame that typically characterize a Phd Thesis. That said, we opted to use a 
less restricted approach in his Research (from an academic or scientific perspective), a Data 
Driven Approach. This is a powerful approach that requires less up-front knowledge, but a 
lot more back-end computation and experimentation. As such, it requires working with a 
smaller sample of the initial dataset, so that you can get results quickly. This small sample 
is to be used as a test harness, where we can have complete faith in.  
You cannot know which algorithm (or algorithm configuration) will perform well or even 
best on each problem before starting to test the algorithm against the dataset. The Data 
Driven approach chooses a middle ground between going with your favorite algorithm on 
one hand and testing all known algorithms on the other hand. 
Optimizing a predictive model requires mostly experimentation and tuning. For any given 
problem, there are many available modelling techniques, and for each technique there are 
many ways to specify and parameterize a model. For the most part, trial and error is the 
only way to identify the best model for a given problem and data set. The “No Free Lunch” 
theorem formalizes this concept (Brownlee, 2016; Domingos, 2015). Therefore, this thesis 
intends to go through a data driven approach where several algorithms are tested against the 
dataset, instead of spending all the time in tuning a specific algorithm. To be able to follow 
this approach and speed up the trial and error efforts, the Caret package that is available in 
A MACHINE LEARNING AND BIG DATA APPROACH TO PREDICT MULTIDRUG 
RESISTANT HOSPITAL ACQUIRED INFECTION IN THE NEXT 72 HOURS 
 
 73 
R is the most useful tool to help test several algorithms with confidence of statistical 
validity (e.g resampling), in a timely manner, and without the need of being an expert in 
each algorithm. 
5.2 MODELLING THE DATA – FINAL DATASET COMPOSITION 
Modelling the Data – Final Dataset composition 
Before applying a ML model, the data must usually be converted into a tabular form. This 
whole process is the most time consuming and difficult process and is depicted in the figure 
below. 
 
Figure 35: Workflow used to convert Raw Data into a data format that is prepared to be used by a 
Machine Learning Model (figure credits to Abhishek Thakur) 
The machine learning models are then applied to the tabular data. Tabular data is most 
common way of representing data in ML or data mining. The labels can be single column 
or multi-column, depending on the type of problem; in this work, the labels were single 
column.  
Each case (row) in the final tabular dataset used in this work was defined as a patient ID, 
plus the patient’s inpatient day (patient ID + inpatient day). Then, the dataset columns are a 
set of variables about the patient’s phenotyping information that are typically spread 
throughout several systems and stored in multiple formats, like lab results, clinical text 
notes, medical image, sensor information, among others. We intent to represent each day of 
a patient’s admission as a high-dimensional feature vector, composed of both variables 
collected once at the time of admission, and those that continue to be measured over the 
course of the hospitalization. With this approach it is expected to obtain a high dimensional 
view of the patient and increase the probability of developing a successful predictive model 
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based on ML techniques. In terms of the outcome variables we modelled the final dataset as 
a binary classification problem (having the HAI MDR bacteria=0; Not having the HAI 
MDR bacteria=1). 
 
Table 10: Some columns of the Multidimensional Dataset built for each patient 
As previously stated, we used three dataset versions of the dataset exposed in table 2. These 
datasets were built using the same predictors, but the outcome variable was different for 
each of these datasets. Each one dataset was meant to predict HAI MDR bacteria in the 
next 72 hours for Blood samples, or Urine samples, or Bronchial Secretions samples 
respectively. 
5.3 R AS THE MACHINE LEARNING TOOLKIT OF CHOICE 
By revisiting Question 1 and Question 4 of this Research Work (Chapter 1), we had to be 
very sharp about the tool to choose from the very beginning of this Work. On one hand, this 
work was supposed to deliver a model that could be used, 24h/7h in a real-life production 
scenario. On the other hand, the tool model would have to be ready for production in the 
research time-frame, even knowing that the model would use thousands of variables. 
In the beginning, a wide range of mainstream software applications were available, starting 
with WEKA, KNIME, SAS, Azure ML, R Studio and others. The main choice here was 
related to using a simple and visual interface, as WEKA or KNIME, or to opt for a 
programming language interface, as R Studio. As this work involved dealing with BigData 
datasets with thousands of variables, working in simple applications as WEKA would have 
three serious obstacles: 
Inpatient Day Weekday - 1 Weekday - 2 Weekday (..n) Age
Type of 
Admission
Time Since 
last visit to 
the Hospital 
(in days)
Average of 
Vitalsign  
Type1 in the 
last 36hours
Average of 
Vitalsign 
Type(..n) in 
the last 
36hours
Average of 
Lab Result 
Type 1 in the 
last 36hours
Average of 
Lab Result 
Type (..n) in 
the last 
36hours
MDR Bacteria 
in the next 72 
hours?
1 1 0 0 26 Urgent 30 36,5 105 3,2 93,2 0
2 0 1 0 26 Urgent 30 36,5 105 3,2 93 0
3 0 0 0 26 Urgent 30 35 105 3,6 93 1
(..) -> Aditional 1600 variables
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1. All the data is usually loaded into memory, and tools as WEKA have serious 
memory limitations. Parallelization tasks do not exist in these tools and 
therefore, each experiment with these datasets would be very slow; 
2. All the variables would have to be treated in a visual interface, by using the 
visual commands available. When dealing with a dataset with a dimensionality 
of thousands of variables, where the need to treat several types of variables in 
parallel and with a single command, is mandatory, relying on a visual tool 
which needs a lot of human input would be unfeasible; 
3. It is quite difficult to create reproducible tasks in tools such as WEKA. As this 
work involved hundreds of steps to treat the dataset in each experience, doing it 
over and over again, countless times, relying on tools where all this work would 
have to be done manually, without an automated and systematic approach, 
would be unfeasible. 
Regarding the programming language to use for this work, R was the programming 
language chosen, using R Studio. The reasons for choosing R were: 
 R has a rich ecosystem of cutting-edge packages and active community; 
 R and visualization are a perfect match; 
 R is the most popular language for Machine Learning and its popularity is growing 
every day; 
 R Server Engines are now being integrated into the major Database Vendor 
Products (ex: SQL Server 2016). This represents an opportunity to easily integrate 
R with the data coming from operational systems, in an easy and transparent 
environment and, therefore, this is a key aspect to use R as the programming 
language in a production system. 
 
 
 
A MACHINE LEARNING AND BIG DATA APPROACH TO PREDICT MULTIDRUG 
RESISTANT HOSPITAL ACQUIRED INFECTION IN THE NEXT 72 HOURS 
 
 76 
The importance of the Caret Package 
The Caret package in R is one of the most feature rich packages for doing ML in R. It 
gathers, in one single place, machine learning algorithms from multiple R packages, 
provides a uniform interface and commands to run these algorithms and includes many 
functions for facilitating the model building process. Caret has more than 206 models 
unified into a single operational framework, which is outstanding. 
One of the most complex challenges in Machine Learning are knowing how to best tune 
parameters for each model and evaluate its performance. For instance, Gradient Boosting 
Machine (GBM) is an interesting model but very hard to tune; how to select the best values 
for its several tuning parameters (like number of trees, interaction depth, shrinkage) 
remains a source of hidden knowledge and expertise. To avoid falling into these complex 
scenarios, we used the Caret package extensively because it has a train function called 
“trainControl” that automates complex tasks for training any model, by implementing the 
following algorithm to train each model: 
 for each resampled data set do: 
 hold out some samples 
o for each combination of the tuning parameters 
 do 
 Fit the model on the resampled data set 
 Predict the values of class on the hold out samples 
o end 
o Calculate Area Under the ROC Curve (AUC): the area under the ROC for 
each sample 
o Select the combination of tuning parameters that yields the best AUC 
By making intensive use of the functionalities available in the Caret Package, implementing 
a data driven, fast and powerful approach became feasible. For instance, one of the most 
interesting functionalities about Caret’s train function is that it will fine-tune the parameters 
A MACHINE LEARNING AND BIG DATA APPROACH TO PREDICT MULTIDRUG 
RESISTANT HOSPITAL ACQUIRED INFECTION IN THE NEXT 72 HOURS 
 
 77 
in each model (to a certain extent), saving precious time in the Machine Learning 
parameter’ tuning process. The following diagram illustrates the approach that was used to 
train most of the algorithms used in this work, while maintaining the robustness of the 
models to noise and, their ability to generalize to other datasets. 
 
Figure 36: Workflow used to train the Machine Learning Models using the Caret Package 
resampling and model tuning agile methods 
That said, the Caret Package soon became the tool of choice for this thesis as it involves a 
Data Driven approach with less up-front knowledge about each algorithm particularities. 
5.4 ACCOUNTING FOR UNBALANCED DATASETS 
Since the Exploratory Data Analysis’ step of this research, it became clear that we were 
dealing with some degree of unbalanced datasets, independently of the type of MDR 
bacteria we were trying to predict. In this scenario, building a model that cannot even beat a 
naive classifier that labels every case negative, in terms of the true positive rate, is not 
uncommon.  
Most classification algorithms pursue the objective of minimizing the error rate: the 
percentage of incorrect predicted cases. These algorithms do not account for the difference 
between types of misclassification errors. In particular, they implicitly assume that all 
misclassification errors cost equally, being more sensitive to detecting the majority class 
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and less sensitive to the minority class (Ganganwar, 2012). Due to this unequal class 
distribution, the performance of the existing classifiers tends to be biased towards the 
majority class, mostly due to three main reasons: 
1. Algorithms are usually accuracy driven, i.e., their goal is to minimize the overall 
error to which the minority class, usually, contributes very little; 
2. They assume that there is equal distribution of data for all the classes; 
3. They also assume that the errors coming from different classes have the same cost. 
By assuming a balanced data set, typical algorithms usually give birth to degenerated 
models that do not take into the importance of the minority class. In this thesis’ scenario, 
the cost of missing a minority class (patient being infected) is higher than missing a 
majority class. 
A common solution to this problem of Unbalanced Dataset is to use sampling methods that 
manipulate the training data to balance the class distribution; there are mainly three types of 
sampling methods: 
1. Under-sampling methods that select a small part of the majority class examples and 
add them to the minority class cases; 
2. Over-sampling methods that simply replicate the minority class examples; 
3. Variants of these two general sampling approaches exist. A successful example is 
the SMOTE method (Chawla et al., 2002). The general idea of this method is to 
artificially generate new examples of the minority class using the nearest neighbors 
of these cases. Furthermore, the majority class examples are also under-sampled, 
leading to a more balanced dataset. 
Sampling techniques have some disadvantages, like increasing the risk for overfitting or 
eliminating useful data in undersampling scenarios. Nevertheless, these techniques are still 
a popular way to deal with unbalanced data rather than a cost-sensitive learning algorithm.  
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When training the first Machine Learning algorithms, we will evaluate if these balancing 
techniques have an impact in the predictive performance of the algorithms that will be used. 
Besides balancing techniques, other common approaches, like the correct choice of 
evaluation metrics to train the algorithm, are also useful when dealing with Unbalanced 
Datasets. As reported by Jeni et al. (2013), the choice of evaluation metrics should be 
insensitive to the amount of skew in the testing set. In this work she concluded that, with 
exception of the AUC, all metrics were attenuated by skewed distributions. Therefore, the 
AUC is a good metric for evaluation of classifiers in such datasets, and we will have 
that into account throughout this work. 
5.5 METHODOLOGY USED FOR TRAINING 
Data Driven & Systematic Methodology - Start small with State of the Art Algorithms 
In a recent study called “Do We Need Hundreds of Classifiers to Solve Real World 
Classification Problems?”, published in the Journal of Machine Learning Research on 
October 2014, RF proved to be the most effective and likely to be the best classifier when 
raced against nearly 200 other algorithms averaged over more than 100 data sets (Delgado 
et al., 2014). That said, the first approach used in this thesis will be to see how a RF 
algorithm behaves in the infection dataset and evaluate the predictive power of this 
standalone approach. Besides, we also decided to use some of the algorithms that played a 
key role in getting a top 10 ranking in more than 15 Kaggle competitions (Kaggle, 2016; 
Conort, 2014). Using a Generalized Linear Model (GLM) algorithm is always a good 
choice, at least to establish a baseline of how a simple algorithm is able to perform when 
compared with other complex algorithms. At the end, the algorithms chosen for this work 
were: 
 Random Forests 
 Decision Trees 
 GBM 
 GLM 
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SVMs are also one of the top ranked algorithms in Kaggle competitions. However, by the 
time of this thesis, we did not manage to get SVMs to work in this huge dataset, mostly 
because there were a lot of errors reported by R while training the SVMs algorithms. This 
was mostly related to the fact that SVMs are very sensitive to the datatypes of each 
variable. Therefore, as we were losing significant time trying to solve some of the errors 
reported while training the SVMs algorithms, we opted to leave them out of this thesis, 
allocating them to future research. 
Methodology for training all Algorithms 
In all models that were trained, an identical methodology was used. First, we split the 
dataset into two groups: training datasets and test datasets, by using the 
“CreateDataPartition()” function of the R Caret package (Kuhn, 2015). By default this 
function does a stratified random split of the data. It assures that the train, validation and 
test sets are well balanced, accordingly to the overall population. Therefore, the already 
existing problem of skewed classes is not intensified.  
All algorithms are trained using the “train()” function of the R Caret Package. By default, 
this function will have the following behavior: 
 Type of Resampling: The simple bootstrap is used by default. We will alter the 
default parameter and use one repetition of 10-fold cross-validation, as this is 
currently one of the most widely used methodologies to estimate generalization’ 
performance in ML.  
 The methods for measuring performance: If unspecified, overall accuracy and 
the Kappa statistic are computed. For regression models, root mean squared error 
and R2 are computed. Here, given the unbalanced characteristics of the dataset 
used, the function will be altered to estimate the area under the ROC curve. 
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 Parameter tuning: By default, the function will automatically tune over three 
values of each tuning parameter. These values can be changed using either the 
“tuneLength” or “tuneGrid” arguments. We opted to maintain these default values, 
because training times would become unfeasible if we increased the tuning 
parameters. 
 Choosing the best model while training: The “train()” function will pick the 
tuning parameters associated with the best results. Since we are using custom 
performance measures, the criterion that should be optimized must also be 
specified. In the call to train, we use metric = "ROC" to do this. 
The “train()” function of the R Caret Package is an amazing utility because it allows to use 
a common framework and an unified interface for all the predictive models that we want to 
build, and their related tasks (e.g: resampling methods, parameter tuning strategy). Then, 
we simply specify the type of algorithm that we want to use in the “method” parameter. 
As Domingos (2015a) clearly explains in his famous article, “A Few Useful Things to 
Know about Machine Learning”, it is generalization that counts. In this article, he explains 
that it is very easy to contaminate a classifier if we do not separate all test data from 
any procedures done while training (e.g. parameter tuning procedures). Obviously, 
holding-out data from the very beginning comes at a cost, losing examples to train. But, as 
Domingos (2015a) also explains, this can be mitigated by doing cross-validation, where 
random subsets of the data are used to train several algorithms and a final average of the 
results will demonstrate how well a particular algorithm behaves with this dataset. 
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Figure 37 demonstrates how we applied a common framework to train all algorithms and 
guaranteed that we used a complete separate test dataset in order to obtain a true estimate of 
the generalization performance of each of the algorithms. Inside the 
“CreateDataPartition()” function, we specified that 70% of the data would be used for 
model training and the remainder 30% for evaluating model performance (hold-out). The 
function creates the random splits within each class so that the overall class distribution is 
preserved as well as possible. The R Code related to this implementation is available in 
Figure A2 of Appendix 2, and it illustrates how that common framework was easily built in 
R using the R Caret functions. 
5.6 SOME NOTES ON ENSEMBLE METHODS 
Ensemble based methods can reduce prediction variance by taking the average from a 
collection of different models. The more these individual models are uncorrelated with each 
other, the lower the variance of the ensemble model that is constructed from the individual 
models. 
In this work, we decided to apply great effort in one type of model, called Random Forest, 
as Ensemble methods like RF are now the standard (Domingos, 2012).  
Figure 37: Diagram of the Training Procedure used for all Algorithms, holding-out a test dataset, with 
the help of R Caret functions 
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In RF, multiple trees are trained by repeatedly sampling the set of observations with 
replacement. Each tree is constructed using a different bootstrap sample from the original 
data. About one-third of the cases are left out of the bootstrap sample and not used in the 
construction of the trees. These cases that are left out of RF tree construction process will 
allow RF to produce an out-of-bag (oob) error estimate which is also an unbiased estimate 
of the error rate of this algorithm. 
When a new input (case) is given to RF, it runs down all of the trees. The result, in the case 
of categorical variables, is a majority voting among all trees. 
Particularly, RF seemed to be a great algorithm to use in this work, for many reasons:  
1. It can deal with messy data; 
2. It takes no assumptions that the response has a linear (or even smooth) relationship 
with the predictors; 
3. It automatically does a good job of finding interactions among variables; 
4. It can output a list of predictor variables that it believes to be important in predicting 
the outcome. This functionality is valuable, in order to share insights about the 
algorithm reasoning with the clinicians. 
5.7 TRAINING ALGORITHMS ON BIG DATASETS 
There is a great need to use algorithms that are capable of building classiﬁers from Big 
Datasets and that are, simultaneously, computationally efﬁcient and scalable (Amado et al., 
2001).  
While starting to train the first algorithms on the dataset used in this research, it soon 
became clear that many algorithms proved to be very slow while training in a dataset of this 
dimensionality. Therefore, for some algorithms, it became proved that using parallelization 
libraries in R would be absolutely crucial, in order to be able to do several tests in a timely 
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manner. The idea is that the computations could be spread across different "workers" to 
increase the computational efficiency. Resampling procedures are vastly used by the R 
Caret package as the primary approach for optimizing predictive models with tuning 
parameters. In these computationally heavy methods, many alternate versions of the 
training set are used to train the model and predict a hold-out set. This process is repeated 
many times to get performance estimates of how well the model generalizes to new 
datasets. Gradient Boosting Machines Algorithm is an excellent example of a complex 
algorithm that, although being a sequential algorithm, benefits from parallel processing 
when used inside the Caret package. 
 
Figure 38: Impact of parallelization on the training time of a GBM algorithm (measured on a sample 
of the dataset used in this work) 
By making use of the “registerDoParallel()” function of the “doParallel” R package, while 
training algorithms for this work, all seven cores of the our laptop maxed out at 100% 
utilization. The code we used to implement this parallelization framework for training all 
algorithms faster is available in Figure A.3 of Appendix 2. 
Other type of problems that frequently appear, while training algorithms on datasets of this 
size, are software errors. Throughout this work we had to deal with hundreds of errors in R 
Studio and WEKA, most of them related to the increasing complexity of trying to model a 
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dataset with thousands of variables. This fact posed great challenge to the modelling phase, 
and it was a clear obstacle to proceed faster.  
In the two figures below, it is possible to see the type of errors obtained, while trying to 
train a dataset with 1300 observations and 1464 variables (blood HAI MDR resistant 
bacteria in the next 72 hours). 
 
Figure 39: Print Screen of WEKA memory errors due to the Big Data nature of the dataset used in 
this work 
 
 
Figure 40: Print Screen of R Studio memory errors due to the Big Data nature of the dataset used in 
this work 
5.8 WEKA FOR FAST MODELING  
Throughout the course of this work, because of the increasing number of errors we had to 
deal with in R Studio, using just R for the modelling process became unfeasible because it 
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was slowing down the train and test processes. Besides, just to see a ROC curve or a 
classification matrix for each algorithm, we had to specify a series of R commands with a 
specific syntax. This took even more time out of the process, especially in the phases where 
we were interested in a quick analysis. Therefore, we had to use WEKA to speed up this 
process.  
The choice of WEKA revealed to be a wise decision, since WEKA was able to train 
random forest models in just a few minutes and to observe the associated ROC curves and 
classification matrix very quickly. From this stage forward, we just used R for parameter 
tuning and to obtain the variable importance tables. WEKA was, therefore, used for all the 
Results analysis phase. 
  
A MACHINE LEARNING AND BIG DATA APPROACH TO PREDICT MULTIDRUG 
RESISTANT HOSPITAL ACQUIRED INFECTION IN THE NEXT 72 HOURS 
 
 87 
6. EVALUATION 
6.1 EVALUATING MACHINE LEARNING ALGORITHMS 
The first thing we did in the evaluation phase was to choose the algorithm we were going to 
predominantly work with. For that, we had to evaluate how a series of algorithms was 
going to perform in this dataset, in order to identify the best performing algorithm. As we 
applied a Data Driven Approach, and we did not have time to learn the specificities of 
parameter tuning that each algorithm involves, we supported ourselves on the R Caret 
package to do all this work. By using the automated parameter tuning features of the Caret 
package, it was easy to see the best performing algorithm. Figure 41 illustrates how caret 
automates the process of parameter tuning to help us deal with all this complexity. 
 
 
Figure 41: Print of R Caret Package doing an automated parameter tuning while training a GBM 
model on a dataset to predict HAI MDR bacteria on Blood samples 
We replicated this approach for all the 4 different algorithms (GBM, Random Forests, 
Decision Trees and GLM) were trained. The dataset used for training was the dataset which 
was meant to predict HAI MDR bacteria in the next 72 hours in blood samples. In the 
following Table it is possible to see a summary of the several algorithms used in this 
dataset.  
 
A MACHINE LEARNING AND BIG DATA APPROACH TO PREDICT MULTIDRUG 
RESISTANT HOSPITAL ACQUIRED INFECTION IN THE NEXT 72 HOURS 
 
 88 
 
Table 11: Summary of the performance of different algorithms on the dataset used to predict HAI 
MDR bacteria (blood samples). 
To compare the performance of these different algorithms, we used the AUC, as this is a 
widely accepted metric to evaluate algorithms (Gama et al., 2012). 
Table 11 demonstrates that RF is the best performing algorithm for this problem and, 
therefore, RF was the algorithm chosen to be applied throughout this work. It is possible to 
see that, besides RF, only the GBM algorithm managed to get a good performance of 0.93 
(AUC), while decision trees algorithm revealed to have very poor performance and logistic 
regression algorithm did not converge.  
6.2 PERFORMANCE RESULTS ON DIFFERENT BIOLOGICAL SAMPLES  
As previously mentioned in Chapter 3, in this work we learned three different models; they 
are all based on the same sets of variables, but with a distinct outcome. The first model will 
be named “blood samples model”, and was the first to be constructed. In this model, the 
outcome variable is the appearance of a HAI MDR bacteria in blood samples results, in the 
following 72 hours. The second model will be named the “bronchial secretions model”. The 
difference from the previous model is that the outcome variable is the appearance of a HAI 
MDR bacteria in bronchial secretions samples results, in the following 72 hours. Finally, 
the third model will be named “urine samples model”, which predicts the appearance of a 
HAI MDR bacteria in urine samples results, in the following 72 hours. 
These three models were learned over three datasets with 1464 attributes each. However, 
each model learns over a different number of cases, because, blood, urine and bronchial 
secretions analysis are not requested to all patients. For instance, microbiological blood 
analyses are requested only when suspecting of serious infections. 
Re-evaluation on Separate 
dataset (performance for the 
class "Infected")
Model TrainMethod (%) Cases Train/Test
Class Unbalance 
(Positive/Negative) TimetoTrain (minutes)
Type of Parameter 
Tunning AUC
gbm (n.trees = 150, interaction.depth = 3, shrinkage = 0.1
 and n.minobsinnode = 10) 10 Fold CV 70%/30% 20.8%/79.2% 1,5 Automated - By Caret 0,9305
rForest (n.trees= 300, mtry=1463) 10 Fold CV 70%/30% 20.8%/79.2% 15 Automated - By Caret 0,9897
DecisionTrees-Cart (complexity parameter (cp) =0,01845) 10 Fold CV 70%/30% 20.8%/79.2% 1 Automated - By Caret 0,3704
glm 10 Fold CV 70%/30% 20.8%/79.2% 2 Automated - By Caret algorithm did not converge 
Blood Samples
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Random Forest tuning 
In this work, our main efforts were concentrated in building models to predict HAI MDR 
bacteria in the next 72 hours, in blood samples. We also tried to test the performance of RF 
algorithms to predict HAI MDR bacteria in urine and bronchial secretions samples, but the 
major research work was done in blood samples. 
There are two main parameters that can have great impact in the performance of the 
Random Forest algorithm. Those parameters are: 
 mtry: Number of variables randomly sampled as candidates at each split; 
 ntree: Number of trees to grow. 
The "correct" value for the “ntree” parameter was obtained using several tests for the 
number of trees used. It became quite apparent that, with a little tinkering in the number of 
trees used by the model, the predictions of the model did not change much after a certain 
number of trees was reached, 300 trees in this case. Table 12 demonstrates these tests. 
 
Table 12: Summary of the performance of different algorithms on the dataset used to predict HAI 
MDR bacteria (blood samples). 
The "correct" value for the “mtry” parameter that is recommended in the literature comes 
from the formula mtry=floor(sqrt(ncol(x))). In this case, as the dataset used to train the 
model had 1454 features, the mtry parameter to use should be 38. However, we tried to 
confirm this value by using the R Caret package parameter tuning grid search features 
accordingly to the value of the AUC (figure 42). 
Model TrainMethod (%) Cases Train/Test
Class Unbalance 
(Positive/Negative)
TimetoTrain 
(minutes) AUC Precision Recall\Sensitivity\ (or TP Rate) F-Measure
rForest 100 
trees (mtry=11) 10 Fold CV 70%/30% 20.8%/79.2% 0.5 0.936 100 0.043 0.083
rForest 300 
trees (mtry=11) 10 Fold CV 70%/30% 20.8%/79.2% 1 0.967 100  0.026 0.05 
rForest 500 
trees (mtry=11) 10 Fold CV 70%/30% 20.8%/79.2% 1,5 0.964 100  0.017  0.034 
Blood Samples
Re-evaluation on Separate dataset (performance for the 
class "Infected")
A MACHINE LEARNING AND BIG DATA APPROACH TO PREDICT MULTIDRUG 
RESISTANT HOSPITAL ACQUIRED INFECTION IN THE NEXT 72 HOURS 
 
 90 
 
Figure 42: Selection of the best value for mtry using grid search parameter tuning of Caret Package. 
As figure 42 demonstrates, the correct number of features to use for the RF algorithm is 
near 38. Therefore, we used mtry=38 in WEKA for the number of random features chosen 
in the RF models. This is aligned with the recommended value for the mtry parameter in 
the literature, which is given by the formula mtry=floor(sqrt(ncol(x))), where x is the 
number of columns of the dataset. 
Blood Samples Model (next 72 hours) 
We trained our model in a training set that was obtained using a 70% stratified random 
sample of the initial dataset. This training dataset had 1300 inpatient days (cases), being 
271 days considered positive cases, since a positive result of HAI MDR bacteria appeared 
in a blood sample of those case in the following 72 hours of date index. 
 
Figure 43: Histogram of the Outcome variable (“MDRXDRSANGUE72”) in the Blood samples 
model (some text in Portuguese). 
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After training our RF algorithm with the parameters learned in the Random Forest tuning 
section, we applied our algorithm to a separate validation set of 557 inpatient days, with 
166 cases of HAI MDR bacteria in blood samples, in the next 72 hours. 
As Table 13 demonstrates, this model yielded an area under the receiver operating 
characteristic curve (AUROC) of 0.987. Given that the AUC obtained was almost near 1, 
we decided not to apply balancing techniques to the dataset because the result would not 
change significantly. 
 
Table 13: Evaluation results for the Blood Samples Model, considering the “Infected” class (HAI 
MDR bacteria in the next 72 hours). 
In figure 44 we display the ROC curve for this model, which depicts the true positive rate 
(Sensitivity) as the function of the false positive rate (100-Specificity) for different cut-off 
points of a parameter. 
 
Figure 44: ROC Curve for the Blood Samples Model. 
Model TrainMethod (%) Cases Train/Test
Class Unbalance 
(Positive/Negative)
TimetoTrain 
(minutes) AUC Precision Recall\Sensitivity\ (or TP Rate) F-Measure
rForest (mtry=38, ntrees=300, seed= 2015) 10 Fold CV 70%/30% 20.8%/79.2% 1 0,987 1 0,491 0,659
Blood Samples
Re-evaluation on Separate dataset (performance for the 
class "Infected")
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Each point on the ROC curve represents a sensitivity/specificity pair corresponding to a 
particular decision threshold. The area under the ROC curve (AUC) is a measure of how 
well a parameter can distinguish between two infected groups (infected / not infected). 
Just looking at the ROC curve is not enough. We need to critically look at the classification 
matrix generated by the model, to see how many cases are caught and missed. 
 
Figure 45: Classification Matrix for the Blood Samples Model regarding HAI MDR bacteria in 
the next 72 hours (some text in Portuguese). 
By looking at the confusion matrix exposed in Figure 45, we can immediately realize that 
our model only catches 49.1% of the infected patients, if we accept the default threshold of 
0.5 that WEKA uses, in order to distinguish infected from non-infected patients. The 
typical threshold value of 0.5 that WEKA uses, means the predicted probability of 
"positive" (infected) must be higher than 0.5 for the instance to be predicted as "positive” 
(infected). 
Before playing with the threshold values of any model, we need to think carefully about the 
real purpose that these models will have in a real life scenario. In that sense, the system we 
propose in this thesis is meant to fire alerts whenever the probability of a patient getting a 
positive result of a HAI MDR bacteria is significant. In that sense, positive cases are the 
ones we were after.  
If we used the 0.5 threshold, although we would benefit from a 100% accuracy when 
predicting infected patients, we would only catch 49.1% of them. As we were more 
interested in having a good balance between the positive predictive value and the recall, we 
had to look for the perfect threshold to select in this model, in order to catch a significant 
number of positive cases, and still have good precision when flagging them. 
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Searching for the optimal threshold value for classification accuracy 
WEKA has an amazing functionality, which is called “cost benefit analysis screen”, that 
allows users to change the default classification threshold of a classifier, in the search for 
its optimal value. In this functionality, there is a slider available to change the threshold and 
interactively see the new confusion matrixes generated accordingly, in the bottom left hand 
corner (see figure 46).  
 
Figure 46: WEKA cost benefit analysis screen displaying the results of the Blood Samples, with a 
0.51 threshold (some text in Portuguese). 
Figure 46 demonstrates how our model behaves using a 0.51 threshold to flag infected 
patients.  This is near the default threshold of 0.5 used by WEKA to produce the 
classification matrix showed in the “Classify” screen of WEKA. As it can be seen in the 
left plot of this figure (Plot: ThresholdCurve), less than 50% of infected patients are caught 
when the model is parameterized using a 0.51 threshold. The idea is to see the “cross” on 
this plot going in the upper direction. 
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Looking at the curve illustrated in the right plot of figure 46 (Plot: Cost/Benefit), 
specifically at the “cross” position on that plot, we can see that it clearly shows that we are 
not minimizing the cost of this model, and that there is still margin to do it. By clicking on 
the “Minimize Cost/Benefit” button at the right bottom corner of the window, we can easily 
find the threshold corresponding to the minimum cost. The result of doing this action is 
exposed in figure 47. 
 
Figure 47: WEKA cost benefit analysis screen displaying the results of the Blood Samples, with a 
0.31 threshold, after running the Minimize Cost/Benefit function (some text in Portuguese).   
After running the Minimize Cost/Benefit function, WEKA immediately selected a score 
threshold of 0.3167. This means we should start flagging patients as infected earlier in 
terms of their predicted probability of being "positive". Looking at the curve illustrated in 
the left plot of Figure 47 (Plot: Cost/Benefit), we can see that the “cross” position went up 
when compared with the previous 0.51 threshold. This means that our recall for infected 
patients was increased, and we can see that the recall went up to an excellent value of 0.87 
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by clicking over that cross. This is confirmed by the classification matrix on the left down 
corner, which reveals that we correctly predicted 102 infected patients (almost the double 
when compared with the 0.51 threshold) and we are doing it with a precision of 0.94.  
With these results, by running with a 0.3167 parametrized threshold, this model would be 
welcomed by the physicians, because it detects most of the infected patients (87.9%) with 
94% precision. Among the 116 infected patients, 102 would have been caught and 
classified as infected. 
Bronchial Secretions Samples (next 72 hours) 
We trained our model in a training set that was obtained using a 70% stratified random 
sample of the initial dataset. This training dataset had 2523 inpatient days (cases) and 849 
days were positive cases because a positive result of HAI MDR bacteria appeared in 
bronchial secretions samples of that case in the following 72 hours of date index. 
 
Figure 48: Histogram of the Outcome variable (“MDRXDRSECRECOES72”) in the Bronchial 
Secretions model (some text in Portuguese). 
After training our RF algorithm with the parameters learned in the Random Forest tuning 
section, we applied our algorithm to a separate validation set of 1080 inpatient days with 
363 cases of HAI MDR bacteria in blood samples, in the next 72 hours. 
As Table 14 demonstrates, this model yielded an area under the receiver operating 
characteristic curve (AUROC) of 0.965. Given that the AUC obtained was almost near 1, 
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we decided not to apply balancing techniques to the dataset because the result would not 
change significantly. 
 
Table 14: Evaluation results for the Bronchial Secretions Samples Model, considering the 
“Infected” class (HAI MDR bacteria in the next 72 hours) 
Compared with the Blood samples model, for the same 0.5 default threshold, this model is 
more appealing to be used in real life because it would catch a significant proportion of the 
positive cases (recall = 0,785) while still maintaining a good precision (precision = 0,934). 
Obviously, the blood samples model threshold can be changed and achieve even better 
results, because the AUC of the Bronchial Secretions samples model (AUC=0,965) is lower 
than the blood samples model (AUC=0,987). 
Urine Samples (next 72 hours) 
We trained our model in a training set that was obtained using a 70% stratified random 
sample of the initial dataset. This training dataset had 4049 inpatient days (cases) and 797 
days were positive cases because a positive result of HAI MDR bacteria appeared in a urine 
sample of that case in the following 72 hours of date index. 
 
Figure 49: Histogram of the Outcome variable (“MDRXDRURINA72”) in the Urine samples model 
(some text in Portuguese). 
Model TrainMethod (%) Cases Train/Test
Class Unbalance 
(Positive/Negative)
TimetoTrain 
(minutes) AUC Precision Recall\Sensitivity\ (or TP Rate) F-Measure
rForest (mtry=38, ntrees=300, seed= 2015) 10 Fold CV 70%/30% 33.6%/66.4% 1 0,965 0,934 0,785 0,833
Bronchial Secretions Samples
Re-evaluation on Separate dataset (performance for the 
class "Infected")
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After training our RF algorithm with the parameters learned in the Random Forest tuning 
section, we applied our algorithm to a separate validation set of 1734 inpatient days with 
797 cases of HAI MDR bacteria in urine samples, in the next 72 hours. 
As Table 15 demonstrates, this model yielded an area under the receiver operating 
characteristic curve (AUROC) of 0.96. This model took 10 times more time to train, when 
compared with blood samples and bronchial secretions samples model, because it had more 
cases to learn from. 
 
Table 15: Evaluation results for the Urine Samples Model, considering the “Infected” class (HAI 
MDR bacteria in the next 72 hours). 
In an effort to obtain a better AUC, we tried to apply the SMOTE technique to balance the 
dataset, with 5 nearest neighbors and a percentage of 100% SMOTE instances to create. 
This altered the number of positive cases, from 797 to 1594 positive cases. However, the 
impact of this procedure in terms of the AUC of this model, when tested on a separate test 
dataset, was none, because the AUC obtained was the same (0.96). 
Accounting for Leakage and Overfitting  
Considered as “one of the top ten data mining mistakes”, leakage is basically the 
introduction of information about the data mining target, which should not be legitimately 
available to mine from. This issue has been revisited by several Machine Learning 
textbooks as well as KDD-Cup competitions (Perlich et al., 2011). 
Pyle (1999) refers to this leakage phenomenon, in the context of predictive modeling, as 
anachronisms (i.e. something that is out of place in time), and says that "too good to be 
true" performance is "a dead giveaway" of its existence. 
After analyzing the results obtained in all our models, we remained skeptic about such 
results. Although the risk of overfitting and leakage was mitigated by the cross-validation 
Model TrainMethod (%) Cases Train/Test
Class Unbalance 
(Positive/Negative)
TimetoTrain 
(minutes) AUC Precision Recall\Sensitivity\ (or TP Rate) F-Measure
rForest (mtry=38, ntrees=300, seed= 2015) 10 Fold CV 70%/30% 19,6%/80,34% 10 0,96 1 0,449 0,619
Urine Samples
Re-evaluation on Separate dataset (performance for the 
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techniques while training, and the separate hold-out test dataset while testing, it could still 
occur.  
To be completely sure that overfitting and leakage was not happening in our “too good to 
be true results”, we decided to test our models against a 2016 dataset. The results are 
detailed in the following point. 
6.3 PERFORMANCE RESULTS ON COMPLETELY UNSEEN DATASET 
After learning three models using 2015 datasets (training data obtained using stratified 
random sample of 70% of the 2015 dataset), we were faced with outstanding results (all 
models with AUC>0.9) in the hold-out datasets (hold-out data obtained using stratified 
random sample of 30% of the 2015 dataset).  
We remained skeptic about the results that our models were presenting using 2015 data, 
and we decided to use a completely unseen dataset, of another year, 2016. For that test we 
used a dataset composed of inpatient days related with the 1st semester of 2016.  
These 2016’ datasets (referring to blood, bronchial secretions and urine samples) were 
transformed with the exact same R code that was applied to the 2015 datasets, in the feature 
engineering stage.  
This means, for instance, that we applied the standardization statistics obtained in 2015 to 
the 2016’ test set. Therefore, we used the mean and the standard deviation from the training 
set to standardize the testing set values. On the other hand, the missing value replacement 
procedures, in features such as vital signs or blood results, were done using the 2016 
population. In that sense, null values were replaced by the median value of 2016 in these 
features.  
As we had all the 2015 data at our disposal, we learned three models using all the 2015 data 
and tested in the 1st semester of 2016. The models learned using 2015 data had similar 
performance when compared with the models learned over a 70% random sampling of the 
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2015 data. However, when we tested these models over the 2016 data, the results were 
quite different, as Figure 50 demonstrates: 
 
Figure 50: Evaluation results for the Blood, Bronchial Secretions and Urine Samples Models, 
considering a 2016 test set. 
6.4 VARIABLE IMPORTANCE – DOCTORS FEEDBACK 
After having obtained good performance results from the Predictive Models trained in the 
previous chapters, we decided to do a series of meetings with the clinicians in order to 
obtain their sensitivity for accepting the results of these algorithms. For that meeting, we 
took the most important variables that Random Forests selects while training, which are 
given by the “varimp()” function. 
For each predictive model learned (blood, urine and bronchial secretions), we calculated the 
top 20 variables in terms of importance. However, given the short availability of 
physicians, we decided to only ask for their critical opinion about the top 14 variables in the 
blood samples model and about the top 5 variable in the bronchial secretions models. Most 
of our focus in the discussion with clinicians was around the model that predicted HAI 
MDR bacteria in blood samples, because infections in the blood are the most worrying type 
of infections. 
Blood Samples – Importance of Variables in predicting HAI MDR bacteria 
The following plot reveals that, for the predictive model for HAI MDR bacteria in the 
blood, the first 8 variables have a lot more impact in terms of the relative importance, since 
Model TrainMethod
Class Unbalance 
(Positive/Negative) 
in 2015
Class Unbalance 
(Positive/Negative) in 
2016 AUC Precision
Recall\Sensitivity\ 
(or TP Rate) F-Measure
Blood Model rForest (mtry=38, 
ntrees=300, seed= 2015) 10 Fold CV 20.8%/79.2% 14.7%/85,3% 0,689 0,125 0,006 0,012
Bronchial Secretions 
Model rForest (mtry=38, 
ntrees=300, seed= 2015) 11 Fold CV 33.6%/66.4% 28.9%/71.1% 0,706 0,535 0,34 0,416
Urine Model
rForest (mtry=38, 
ntrees=300, seed= 2015) 12 Fold CV 19,6%/80,34% 21.0% /79.0% 0,633 0 0 0
Re-evaluation on 2016 dataset (performance for the class "Infected")
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the importance plot stabilizes from variable 8 (variable named “VARIACAO7D_CAT10”) 
onwards. 
 
Figure 51: Plot illustrating the relative importance of each variable in the Blood samples model 
In the following Table, it is possible to observe the description of each of the variables 
illustrated in the variable importance plot of Figure 51, together with the physician’s 
feedback regarding the top 14 variables: 
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Figure 52: Description of the top 20 variables of the Blood samples model, in terms of variable 
importance, together with physician’s notes about some of them 
In Figure 51 and also in Figure 52, it is possible to observe that the average value of 
potassium in the previous 7 days is the most important variable in the blood samples model. 
As this was a surprise for physicians, because they did not find an immediate relationship 
Field Name Field Description Importance Physicians notes
AVG_7D_CAT6 Potassium - (Average Value (last 7days))
100.00
We don't see an immediate relationship between 
potassium and this kind of infection. However, there 
might be a relationship. We need to study some papers 
about this to give a concrete answer
MIN_7D_CAT6 Potassium - (Minimum Value (last 7 days)) 99.30 Same as previous note about potassium
X151_seg
Anti-infectious Drugs used in Eye Diseases  - 
Consecutive Days on Therapy
95.49
It makes sense, however, few patients are caught because 
these drugs are used in a small number of patients
X151_acm
Anti-infectious Drugs used in Eye Diseases - 
(Cumulative Days on Therapy) 91.69 Same as previous note about Anti-infectious Drugs
X11_seg Antibacterial Drugs - (Consecutive Days on Therapy)
90.64
It makes sense, because Antibacterial Drugs induce 
resistance in bacteria and, therefore, patients that take 
these drugs for long periods tend to have more infections
SERVRESP_Cirurgia.Vascul
ar
Current department in charge of the patient is 
Vascular Surgery (Yes/No)
88.43
It makes sense, it's well known that this department 
makes an excessive use of antibacterial drugs and, 
therefore, patients in this department have more 
infections
X212_seg
Analgesics (Narcotics) - (Consecutive Days on 
Therapy)
86.33
It makes sense, the system is probably flagging patients 
that are on a Intensive Care Unit (taking Narcotics) and, 
therefore, these are vulnerable patients that tend to be 
more susceptible to infections
VARIACAO7D_CAT10
Temperature - (Positive/Negative Variation between 
first and last measurement (last 7 days))
86.17
This is an important variable for any kind of infection, but 
it is not specific of blood infections. We know that a rising 
temperature is an important sign of any infection.
X13_seg
Artificial Nutrition Drugs - (Consecutive Days on 
Therapy)
80.74
It makes sense, the system is probably flagging patients 
that are on a Intensive Care Unit (taking Narcotics) and, 
therefore, these are vulnerable patients that tend to be 
more susceptible to infections
MIN_7D_CAT1 Creatinine - (Minimum Value (last 7 days))
78.73
We believe that the system is catching patients with Renal 
Failure here. We know that patients with renal failure 
have more infections
RHSJ_Escherichia.coli.Ge
ntamicina
Hospital Susceptibility Rate of Escherichia Coli 
bacteria to Gentamicin Antibiotic (last 90 days) 77.92 No comments about this, needs to be further investigated
IDADE_DIAS Patient's Age (in Days)
77.59
This is an important variable for any kind of infection, but 
it is not specific of blood infections. Older patients are 
more susceptible to have any kind of infection.
ULTIMA7D_CAT10 Temperature - (Last Measured Value (last 7 days)) 77.07 Same as previous note about temperature
servicof_entrada_hsj_Neu
rologia.Adultos
Admission to the hospital through the Neurology 
Department (Yes/No)
76.19
Should be further investigated to see if patients who are 
admitted in the Neurology department have more 
infections
AVG_7D_CAT10 Temperature  - (Average Value (last 7days)) 75.84
MIN_7D_CAT15 Sodium Level - (Minimum Value (last 7 days)) 75.03
SERVRESP_Int.Valongo.Med
icina.Interna
Current department in charge of the patient is Internal Medicine (Yes/No)73.04
SERVFISICO_Oftalmologia Current department in charge of the patient is Ophthalmology (Yes/No)72.95
RHSJ_OutrosMicroorganism
os.Fosfomycin
Hospital Susceptibility Rate of general bacteria to Fosfomycin Antibiotic (last 90 days)
69.85
MAX_7D_CAT18 Consciousness Level - (Maximum Value (last 7 days)) 69.80
BLOOD SAMPLES MODEL
(There was no time to obtain notes about these variables)
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among infected patients and this variable, we decided to do a box-plot of both these 
variables, which is illustrated in Figure 53: 
 
Figure 53: Box-Plot of the outcome variable (X Axis) and the variable “AVG_7D_CAT6” for the 
blood sample dataset 
Looking at the box-plot of Figure 53, it is possible to see that infected patients, signed with 
the red color have a different behavior in their average value of potassium in the previous 7 
days (variable “AVG_7D_CAT6”) when compared with patients that were not infected 
(green color).  
Bronchial Secretions – Importance of Variables in predicting HAI MDR bacteria 
The following plot reveals that, for the predictive model for HAI MDR bacteria in the 
blood, the first 7 variables have a lot more impact in terms of the relative importance they 
have to the model, because the importance plot stabilizes from variable 7 (variable named 
“IDADE”) onwards. 
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Figure 54: Plot illustrating the relative importance of each variable in the Bronchial secretions 
samples model 
In the following table, it is possible to observe the description of each of the variables 
illustrated in the variable importance plot of Figure 54, together with the physician’s 
feedback regarding the top 5 variables: 
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Figure 55: Description of the top 20 variables of the Bronchial Secretions model, in terms of 
variable importance, together with physician’s notes about some of them. 
In Figure 54 and also in Figure 55, it is possible to observe that the standard deviation from 
average in the last 36 hours of the systolic blood pressure of the patient, is the most 
important variable in the bronchial secretions model. This was also a surprise for 
physicians. Although they recognized that the variation of this parameter is a sign of 
hemodynamic instability and, therefore, more susceptibility to get infections, it is not a key 
factor that they would consider to assess the risk of infection of each patient. In that sense, 
Field Name Field Description Importance Physicians notes
STDEV_36H_CAT12
Systolic Blood Pressure  - (Standard Deviation from Avg (last 
36h))
100.00
It is a sign of hemodynamic instability. 
However, we would not sign this variable as 
one of the most important. Should be further 
investigated
X212_seg Analgesics (Narcotics) - Consecutive Days on Therapy
86.78
It makes sense, the system is probably flagging 
patients that are on a Intensive Care Unit 
(taking Narcotics) and, therefore, these are 
vulnerable patients that tend to be more 
susceptible to infections
X11_acm Antibacterial - (Cumulative Days on Therapy)
78.79
It makes sense, because Antibacterial Drugs 
induce resistance in bacteria and, therefore, 
patients that take these drugs for long periods 
tend to have more infections
MIN_7D_CAT17
O2 Level (Oxygen Saturation) - (Minimum Value (last 7 
days))
73.23
It makes sense, the system is probably flagging 
patients that are on a Intensive Care Unit 
(taking Narcotics) and, therefore, these are 
vulnerable patients that tend to be more 
susceptible to infections
IDADE_DIAS Patient's Age (in Days)
70.63
This is an important variable for any kind of 
infection, but it is not specific of blood 
infections. Older patients are more susceptible 
to have any kind of infection.
ULTIMA7D_CAT10 Temperature - (Last Measured Value (last 7 days)) 59.46
IDADE Patient's Age (in Years) 54.36
PRIMEIRA7D_CAT15 C-Reactive Protein - (First Measurement (last 7days)) 49.16
MAX_7D_CAT7 Sodium Level - (Maximum Value (last 7 days)) 49.13
MAX_7D_CAT10 Temperature  - (Maximum Value in the (last 7days) 48.38
AVG_7D_CAT14 Glucose - (Average Value (last 7days)) 46.19
AVG_7D_CAT17 Oxygen Saturation (O2) -  (Average Value (last 7days)) 44.94
ULTIMA7D_CAT17 Oxygen Saturation (O2) - (Last Value (last 7days)) 43.56
STDEV_7D_CAT10 Temperature - (Standard Deviation from Avg (last 7 days)) 43.55
X43_acm
Anticoagulants and antithrombotic  - Cumulative number of 
Days on Therapy 43.53
PRIMEIRA7D_CAT10 Temperature  - (First Value (last 7days)) 43.06
servicof_entrada_hsj_
Cirurgia.Geral.Intern
amento
Admission to the hospital through the General Surgery 
Department (Yes/No) 42.81
VARIACAO7D_CAT10
Temperature - (Positive/Negative Variation between first 
and last measurement (last 7 days)) 42.51
episBLOAMBanteriores_
ults90d
Had an ambulatory surgery in the previous 90 days before 
admission to the hospital (Yes/No) 41.98
TEMPOULTIMOEPISODIOIN
T
Time (in days) since last inpatient episode (last visit) 41.57
BRONCHIAL SECRETIONS MODEL
(There was no time to obtain notes about these 
variables)
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we thought it would be interesting to do a box-plot of both these variables, which is 
illustrated in Figure 56: 
 
Figure 56: Box-Plot of the outcome variable (X Axis) and the variable “STDEV_36H_CAT12” for 
the bronchial secretions dataset 
Looking at the box-plot of Figure 56, it is possible to see that infected patients, signed with 
the red color have a clearly different behavior in their standard deviation from average in 
the last 36 hours of the systolic blood pressure (variable “STDEV_36H_CAT12”) when 
compared with patients that were not infected (green color). This corroborates what the 
bronchial secretions model exposed in the variable importance analysis, as this variable is 
clearly different among both populations. Therefore, this is an interesting variable to 
distinguish both populations.  
By comparing the blood samples model with the bronchial secretions model, it is possible 
to observe some common variables, which have increased importance in both models. 
These variables are related with: 
 Number of Days on therapy with Antibacterial Drugs; 
 Number of Days on therapy with Analgesics (Narcotics);  
 Variation on Temperature (rising or declining). 
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7. CONCLUSIONS, DISCUSSION AND FUTURE 
WORK 
7.1 SUMMARY  
In this dissertation we developed a novel way to help predicting a serious worldwide threat 
which is the phenomenon of Hospital Acquired Infections caused by MultiDrug Resistant 
(MDR) bacteria. This problem is particularly challenging due to the nature of clinical data, 
which involves taking into account a large number of sparse facts about each patient 
throughout the time, trying to understand if they evolve in opposite directions or influence 
each other, and their relationship with the outcome we are predicting. Nevertheless, we 
demonstrated that a Machine Learning approach might be able to accurately help 
physicians in predicting positive results of HAI MDR bacteria in advance. 
In the current practice physicians rely on their intuition, based on years of experience, and 
also on some patient measurements (blood results, vitals,...) to assess the risk of infection of 
each patient. In the very beginning of this research, we wondered if just by leveraging the 
electronic data at our disposal, using Machine Learning (ML) techniques, would be enough 
to produce accurate predictions about this phenomenon. This was done with the physician’s 
support, as Chapter 2 demonstrates. 
Throughout the work we adopted a vision of automating all the Machine Learning tasks 
possible, as described in Chapter 3 and Chapter 4. We also tried to reduce, as far as we 
could, the amount of previous knowledge needed about each algorithm behavior, making 
extensive use of R packages recognized by the ML community like the Caret package, to 
help automating all the parameter tuning and statistical validation tasks. This vision is 
detailed in Chapter 5.  
We realized that, during the timeframe of this Research, it would be unfeasible to produce a 
fully automated model, in the day after of presenting this work, and still manage to have 
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time to tune our models in order to achieve good results.  That said, we managed to 
automate hundreds of tasks related to Data Extraction, Understanding and Preparation 
phases using SQL and R. This automation will be valuable in the near future to achieve the 
goal that we intended to address with Question 4, to have a fully automated model that runs 
every day (24h/7h), in a real-life hospital production scenario.  
7.2 CONCLUSIONS AND DISCUSSION 
In this work we developed three Models to predict Multidrug Resistant (MDR) Hospital 
acquired Infection (HAI) bacteria in the next 72 hours of an inpatient episode. Each model 
was specialized in predicting HAI MDR bacteria in different biological products: blood, 
bronchial secretions and urine. All the models were able to distinguish infected from non-
infected patients, revealing excellent prediction performance (AUC>0.9), from a clinician 
standpoint, to predict positive results with HAI MDR bacteria in Blood, Urine or Bronchial 
Secretions. This addresses Question 2 and Question 3 posed at the beginning of this work 
(Chapter I). 
One of the main goals of our work was to build a system that, in clinical practice, could fire 
alerts in cases where the probability of a patient getting an HAI MDR bacteria was 
significant. Therefore, we needed to build models that were excellent at predicting positive 
cases (high precision), while obtaining the highest recall (ideally over 80%) possible. In 
that sense, we realized that we could not rely on the default threshold that is used by 
different ML softwares when generating ROC Curves and Classification Matrixes. We 
demonstrated that, an effort to compute the optimal cut-point for our ROC curves (the value 
at which the sensitivity and specificity are maximized) is mandatory in these situations. 
This effort in optimizing cut-off values meant that we were able to catch 78% more positive 
cases (compared with the default cut-off) while only loosing 5.6% in the precision of our 
model (blood samples model).  
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During our work, while going through the evaluation phase of each algorithm, we tried to 
apply best practices such as 10-fold cross validation and hold-out techniques, in order to 
detect overfitting and bias issues and address the real generalization capabilities of our 
models. The performance results we obtained were outstanding and above our initial 
expectations, with most of the models having an AUC over 0.9. However, as the data 
science “too good to be true” kind of reasoning demands, we remained skeptic about these 
results because, having the risk of overfitting and leakage in mind. 
We decided to put our models to a final proof of generalization performance. These models, 
that were initially trained and tested with 2015 data, were now tested against a complete 
isolated dataset, containing the data generated in the first semester of 2016. The results we 
obtained were fairly poor when compared with the 2015 results (Best AUC=0.7). Many 
reasons can explain these results. One of them, as Gama (2012) refers in his book, is related 
to concept drift phenomenon. It is widely accepted that clinical treatments evolve 
throughout the time. As we had done all the learning using 2015 data, and we applied these 
models to cases that only appeared months (or years) after, the old observations can be so 
outdated that they do not reflect anymore the phenomenon that characterizes patients 
treated in 2016. We intend to test the performance of our model in the first few weeks of 
2016 and compare that performance with the performance obtained in posterior periods of 
2016 (near the end of the 2nd semester). If the model performs better in the first few weeks, 
we might to update the model statistics in an ongoing basis, to account for the concept drift 
phenomenon. 
Furthermore, we assume that by doing some of the preprocessing and feature engineering 
work with all the 2015 data, before splitting the data in the training and test datasets, some 
contamination of the training datasets used by the models to learn from, might have 
occurred. Mostly, the contamination is related to the missing values imputation tasks, as 
these missing values were imputed with statistics of all patients of 2015 (including the ones 
we tested from). It must be said that, given the timeframe available, it would be impossible 
to do all the preprocessing tasks for each fold of our training dataset, while applying cross-
validation, because the algorithms would take weeks to run each training cycle. This is 
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something we intend to test in future research work, by using cloud computational 
resources. There’s also another problem when substituting missing values. If the data 
distribution of the 2016 features differs significantly from the distribution of the same 
features in the 2015 dataset, missing values imputation will also differ significantly among 
both datasets and, therefore, our algorithms will not be able to generalize. We did not had 
time to perform a detailed analysis about the distribution of each feature in 2015 when 
compared with 2015, but we intend to do so in future research.  
We are well aware of the fact that our dataset was small (number of cases) and that there 
were thousands of inpatient days that were left out from this work, because these patients 
did not had microbiological lab results. This represents a challenge for future research, to 
observe how our models would behave in completely unseen cases. Yet, we are convinced 
that the results we obtained reveal the potential of applying machine learning techniques to 
patient records. 
We conclude that the main contributions of our work are in the form of feature engineering, 
problem formulation and systematic modeling methodology to predict HAI MDR bacteria. 
Other investigators have tried to fully automate systems to detect “general” HAI infections, 
based on a set of clinical rules (Jacobson et al., 2016). Few systems are using machine 
learning based approaches, and these are either proof of concepts to predict “general” HAI 
or they only account for a specific type of MDR bacteria (Wiens, 2014), (Ehrentraut, 2014).  
Our research adds to these studies by presenting a methodology to obtain a highly 
dimensional feature vector to clinically characterize each patient, obtained and processed in 
an automated fashion, which resulted in ML models that reveal outstanding value of AUC 
when predicting positive results with HAI MDR bacteria. This complex and multifactorial 
clinical dataset will be the basis to train and develop other predictive models more rapidly 
in the future, for distinct clinical areas from the one presented in this work (e.g. predict 
Intensive Care Units admissions in advance), which was also an initial goal of this work. 
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Using advanced ML algorithms like the ones presented in this dissertation, we were able to 
contribute for the improvement of our understanding of the complex dynamics governing a 
patient's health during a hospital stay. By discovering unexpected variables such as 
potassium (Average Value (last 7days)) or blood pressure (Standard Deviation from 
Average (last 36h)) to be highly important in our models that predicted HAI MDR bacteria 
in blood samples and bronchial secretions, respectively, we were able to surprise 
physicians. These insights can help clinicians to identify new patient variables that might 
contribute, or be correlated, with patients that will reveal infections with HAI MDR 
bacteria in their microbiological lab results in the following 72 hours. 
Finally, we conclude that the proposed methodology in this work holds promise for 
enabling the selective allocation of interventions aimed at reducing the rate of HAI MDR 
bacteria, providing physicians with automated tools to match high-risk patients with the 
appropriate interventions earlier. This accounts for one of the major objectives of this 
thesis: to bring added value to physicians. 
7.3 FUTURE WORK 
In this section, we intend to discuss how our work might be developed further, and how the 
limitations we encountered might be overcome. Therefore, we can pinpoint some of the 
future work that lies ahead in each area: 
 Business Problem: We intend to apply the same methodology and 
multidimensional dataset used in this work to build predictive models for each 
specific type of MDR bacteria. In this work we opted to aggregate different types of 
MDR bacteria into a single calculated column that only signed if the patient had 
acquired a HAI MDR bacteria. Further studies are needed to validate the accuracy 
of the system to detect the specific type of HAI MDR bacteria that might appear in 
the microbiological result of the patient (e.g. Methicillin-resistant Staphylococcus 
aureus). This future phase of our research will be valuable to physicians because it 
will allow them to take precise actions in advance about the therapeutic strategy for 
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each patient, by knowing the specific type of agent that is infecting the patient in 
advance. 
 Preprocessing and Dataset Modelling: Given the poor results obtained while 
testing our models in a 2016 separate test dataset, we intend to investigate this 
problem further. Besides applying the preprocessing procedures only after the 
training dataset is generated, and making these procedures run inside each training 
cycle of cross-validation, we also intend to change our strategy for the imputation of 
missing values. In future research we intend to see if by imputing missing values 
based on the previous available value for that specific patient we obtain better 
results from our predictive models. As we were applying the median of all patients 
in these situations, it might distort the reality of that specific patient. These 
procedures will also be applied separately, on the training and test datasets. 
Other area we intend to test in future research is related to the granularity of our 
data about drug consumption. In the beginning of our work we decided to group all 
the drugs in pharmacotherapeutic groups, to reduce dimensionality. However, this 
could have resulted in loosing important features for the predictive model. Using 
this approach, all the antibiotics are grouped into a single pharmacotherapeutic 
group. However, antibiotics have proved correlation with infection episodes. 
Therefore, in future research, we intend to include the specific active principle of 
each antibiotic being administered to each patient as a feature, instead of grouping 
them into a single feature, and see if the predictive models can achieve better 
results. 
 Explanatory Models: Random forests are one of the best "black-box" supervised 
learning methods. When faced with large amounts of data and several predictor 
variables, Random Forests are ideal algorithms to use. However, these algorithms 
lack in interpretation. It is difficult to easily tell how one variable affects each 
prediction, although it is possible to easily create a partial dependence plot which 
shows how the response will change as you change the predictor. 
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While speaking with physicians throughout this work, we concluded that, to be used 
in clinical practice in the near future, these models needed to be interpretable. In 
that sense, the Random forest algorithm that we used extensively in this work, is not 
the best fit in terms of interpretability. Future research is needed before we can 
effectively and succinctly explain why a particular patient is identified as high risk 
of acquiring a HAI MDR bacteria in the next 72 hours. Therefore, the next phase of 
this research will be to work on the interpretability of the models we use, and to 
obtain a trade-off between interpretability and performance. Naive Bayes models 
could be a good choice for healthcare environment, however, more computing 
power will be needed upfront to train these algorithms.  
 Concept Drift: As explained by Gama (2012), in complex systems we need to 
account for cumulative changes in the process that generates the data throughout the 
time, and incorporate subtle or abrupt changes, for instance, in the data distribution, 
and in the evolution of the context we are trying to learn. Therefore, in a real world 
scenario, the idea is to build adaptive models that can constantly update their beliefs 
and conceptions about the data. We intend to develop a systematic approach that 
will retrain our models with new data, in specific time periods each year, in order to 
avoid these concept drift problems. As previously stated, we intend to test the 
performance of our model in the first few weeks of 2016 and compare that 
performance with the performance obtained in posterior periods of 2016 (near the 
end of the 2nd semester). If the model performs better in the first few weeks, we 
might to update the model statistics in an ongoing basis, to account for the concept 
drift phenomenon. 
 Technical Implementation: The Data Warehouse in the hospital where this work 
has been developed is based on Microsoft SQL Server 2012. However, to 
implement the automated system we proposed in this thesis, we will use the new 
capabilities of Microsoft SQL Server 2016, mostly SQL Server R 
Services (advanced analytics in-database with the R language). This is a revolution 
in the database industry because it allows the R language to be interpreted by a 
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relational database. Rather than moving the data from the database to an external 
machine running R, as we did in this work, by using SQL server 2016 we could run 
R scripts directly inside the SQL Server database. Besides, we will be able to train 
our models inside the database, with the full power of CRAN R packages, plus the 
additional features of speed and scalability from the RevoScaleR package.  Once 
our models are prepared, we will be able to perform batch scoring of each case 
inside the database, in an automated fashion. 
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8. APPENDICES  
8.1 APPENDIX 1: ADDITIONAL WORK 
Business Problem Understanding – Doubts and Decisions 
In this section we reveal some of the doubts we had throughout this work to define how we 
were going to model the Business Problem we were trying to tackle. This involved several 
decisions related to the definition of positive and negative cases that we explain in the 
following points: 
Positive Cases - Definition Problem: Clinically speaking, this is very difficult to do 
because if a microbiological analysis is not requested, no positive lab results exist to detect 
if the patient is infected. However, this does not mean that the patient is free of HAI MDR 
bacteria. In the literature, some authors suggest an approach that classifies positive cases as 
the ones having a culture with a multi-resistant agent; while negative cases as all other 
patients that had at least one negative culture (Nascimento et al., 2013).  
Negative Cases - Definition Problem: Microbiological analysis are not routinely 
requested for each patient, especially if the patient does not reveal any signs of infection, 
like fever; thus, there will be dozens of patients, every day, in a hospital’ scenario where 
these analysis were not requested. To account for this problem, we were initially thinking 
about including patients without lab results, together with patients with negative lab results, 
as negative cases. However, we decided to wait for the results of the Business Users 
interview to take the final decision about this matter. 
After conducting interviews with the Business Users (Doctors), our research scope needed 
to be adjusted. We were initially thinking that predicting the risk of infection with MDR 
bacteria in the following 72 hours of an inpatient day would be a task that could be 
accomplished just by using the Electronic Data about each patient. In this scenario, the 
definition of positive cases would be based on the events of patients that had a positive 
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blood result in the laboratory database, for the specific type of MDR bacteria that the model 
was predicting. All the other patients would be considered as negative cases. 
After the interviews with the Business Users, we realized that this objective would be very 
difficult to accomplish. There are two main reasons that the Business Users explained that 
could be an obstacle for the work we were trying to do: 
 Positive Cases definition: In clinical practice, the physician might suspect that the 
patient is infected with a MDR bacteria and never request for lab results. Or, the 
physician might only suspect of a simple infection and, still, do not request for lab 
results. This can happen for many reasons, but one of the most common causes for 
this behavior is related to the success of initial antibiotic therapy. It is common to 
start empirical and, if the patient is evolving well, sometimes, the physician does 
not see the necessity of requesting lab results. 
The conclusion of this behavior in clinical practice is: “Not all positive cases are 
caught by positive lab results”. We assumed that this risk will be lower in 
Bloodstream infections, because, in these situations, analysis are usually requested 
after a suspicion. Therefore, to start this research, the first predictive model 
developed was related with Bloodstream MDR bacteria, leaving the other samples 
(urine and bronchial secretions) for a later stage of the work.  
 Negative Cases definition: This research was initially considering as negative 
cases all the cases that did not had a positive lab result for MDR bacteria in the 
following 72 hours of an inpatient day. However, by listening to physicians and the 
reality of clinical practice, we realized that our initial assumption was incorrect, 
because negative cases were being considered as a mixture of patients without any 
lab result and patients with negative lab results. Among the patients without lab 
results there can be a significant amount of positive cases, doctors explained. If we 
were to consider these cases as negatives this would bring noise to our models. In 
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fact, if a lab request was requested for some of those patients, a positive result could 
appear.  
The conclusion of this behavior in clinical practice is: “A significant proportion of 
positive cases are among cases without any lab results and, therefore, these cases 
cannot be flagged as negative cases”. 
Predictive Model Target – Final Definition: As a result of the interviews conducted with 
the Business Users (Doctors), a slight but meaningful change was introduced to the main 
objective of this work. The initial predictive model we were thinking to develop would be 
able to say, for every patient, if the patient was going to have an infection caused a HAI 
MDR bacteria in the following 72 hours. This new version of our model intends to predict 
the patients which will “have a positive or negative lab result for a MDR bacteria in the 
following 72 hours, in cases where the doctor decides to request for lab results for this 
patient”. Although this modification might sound simple and only related with the 
vocabulary used, it is actually quite profound in terms of the technical aspects related to 
what the model learned and what it can or cannot predict.  
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8.2 APPENDIX 2: R CODE 
# Loading all the necessary libraries 
library(caret) 
library(mldr) 
library(Amelia) 
library(rattle) 
library(caret) 
library(rpart)               
library(GBM)                 
library(dummies) 
library(mice) 
library(Hmisc) 
library(mlr) 
library(ROCR) 
library(funModeling)   
library(pROC)                  
library(reshape2) 
library(Ckmeans.1d.dp) 
library(xgboost) 
library(car) 
 
#Importing the initial dataset 
pima <- read.csv("D:/dataset.csv", sep=";", na.strings="NULL") 
          
         #filter dataset to only account for results that can be classified as Hospital Acquired Infections (HAI) – 3 days after admission to  
         the  Hospital 
         pima<-subset(pima,pima$DX>=3) 
 
# detect which are the columns being treated as factors 
vars <- names(pima) 
factors <- which(sapply(pima[vars], is.factor)) 
lvls <- sapply(factors, function(x) length(levels(pima[[x]]))) 
names(lvls) 
 
#remove columns without any predictive potential for building predictive models 
pima[,"EPISODIOID"]<-NULL 
pima[,"DATAREFER"]<-NULL 
pima[,"DATAREFER.1"]<-NULL 
pima[,"DATA_FALECIDO"]<-NULL 
pima[,"DATACALENDID"]<-NULL 
pima[,"ANO"]<-NULL 
pima[,"COD_ESPECIALIDADE"]<-NULL 
 
# Fixing columns that had some NULL column values, replacing these NULL values cases by text strings or -1/0 
pima$BLOCO<-ifelse(is.na(pima$BLOCO)==TRUE,'SemCirurgiaBloco',as.character(pima$BLOCO)) 
pima$DES_SALA<-ifelse(is.na(pima$DES_SALA)==TRUE,'SemCirurgiaSala',as.character(pima$DES_SALA)) 
pima$GRANDE_PROCEDIMENTO<-
ifelse(is.na(pima$GRANDE_PROCEDIMENTO)==TRUE,'SemCirurgiaProcedimento',as.character(pima$GRANDE_PROCEDI
MENTO)) 
pima$ICD9_MAIS50K<-
ifelse(is.na(pima$ICD9_MAIS50K)==TRUE,'SemCirurgiaICD9Mais50k',as.character(pima$ICD9_MAIS50K)) 
pima$cirurgiasimples<-ifelse(is.na(pima$cirurgiasimples)==TRUE,0,pima$cirurgiasimples) 
pima$cirurgiacomplexa<-ifelse(is.na(pima$cirurgiacomplexa)==TRUE,0,pima$cirurgiacomplexa) 
pima$cirurgiamedia<-ifelse(is.na(pima$cirurgiamedia)==TRUE,0,pima$cirurgiamedia) 
pima$COD_TIPO_CIR<-ifelse(is.na(pima$COD_TIPO_CIR)==TRUE,-1,pima$COD_TIPO_CIR) 
pima$tempo_espera_cir<-ifelse(is.na(pima$tempo_espera_cir)==TRUE,-1,pima$tempo_espera_cir) 
pima$TE_MAIOR_TCA<-ifelse(is.na(pima$TE_MAIOR_TCA)==TRUE,-1,pima$TE_MAIOR_TCA) 
pima$PRIMEIRA_CIRURGIA<-
ifelse(is.na(pima$PRIMEIRA_CIRURGIA)==TRUE,'SemCirurgiaPrimeiraCirurgia',as.character(pima$PRIMEIRA_CIRURGIA) 
 
# Removing from the dataset columns which only had NULL values filled in 
pima <-pima[, colSums(is.na(pima)) != nrow(pima)] 
# Finding and removing from the dataset columns with zero variance (Kaggle competition tip) 
uniquelength <- sapply(pima,function(x) length(unique(x))) 
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pima <- subset(pima, select=uniquelength>1) 
removecolumns <- subset(pima, select=uniquelength==1) 
pima = pima[,!names(pima) %in% removecolumns] 
 
# replacing NULL values with zeros in columns related to the number of days in therapy 
pima[ ,grepl( "acm" , names( pima ) ) ][is.na(pima[ ,grepl( "acm" , names( pima ) ) ])]<-0 
pima[ ,grepl( "seg" , names( pima ) ) ][is.na(pima[ ,grepl( "seg" , names( pima ) ) ])]<-0 
 
# Converting columns that were assumed with “LOGICAL” datatype to NUMERIC datatype 
pima[ ,grepl( "RHSJ_" , names( pima ) ) ] <- as.integer(unlist(pima[ ,grepl( "RHSJ_" , names( pima ) ) ])) 
 
# Converting the outcome columns that have “-1” values (“death before outcome”) to zero 
pima[ ,grepl( "^P_" , names( pima ) ) ][pima[ ,grepl( "^P_" , names( pima ) ) ]==-1]<-0 
 
# features which refer to “Standard Deviation” of variables, that are filled with NULL values, should be replaced by -l 
pima[ ,grepl( "STDEV" , names( pima ) ) ][is.na(pima[ ,grepl( "STDEV" , names( pima ) ) ])]<-1 
 
# features which refer to “Variation in Value” of variables, that are filled with NULL values, should be replaced by 0 
pima[ ,grepl( "VAR" , names( pima ) ) ][is.na(pima[ ,grepl( "VAR" , names( pima ) ) ])]<-0 
 
# features which refer to “Signal of variation” of variables, that are filled with NULL values, should be transformed to factor 
datatype 
pima[ ,grepl( "SINALVAR" , names( pima ) ) ]<- as.factor(unlist(pima[ ,grepl( "SINALVAR" , names( pima ) ) ])) 
 
# Catch all numeric features related to “category types” of vital signs and biochemical lab results 
names(pima[ ,grepl( "_CAT" , names( pima ) ) ][sapply(pima[ ,grepl( "_CAT" , names( pima ) ) ],is.numeric)]) 
colunasnumericasSVAnalises <- names(pima[ ,grepl( "_CAT" , names( pima ) ) ][sapply(pima[ ,grepl( "_CAT" , names( pima ) ) 
],is.numeric)]) 
 
#Impute median value (of all column)  to each feature related to “category types” of vital signs and biochemical lab results , when 
NULL values are detected 
pima[,names(pima) %in% colunasnumericasSVAnalises]<-apply(pima[,names(pima) %in% colunasnumericasSVAnalises], 2, 
function(x) ifelse(is.na(x), median(x, na.rm=T), x)) 
 
# Convert columns related to “susceptibility rates” to numeric datatype, as these were being considered as factors 
#sapply(pima[ ,grepl( "^R_" , names( pima ) ) ], function (x) class(x)) 
pima[ ,grepl( "^R_" , names( pima ) ) ]<-as.numeric(unlist(pima[ ,grepl( "^R_" , names( pima ) ) ])) 
 
#Impute median value (of all column)  to each feature related to susceptibility rates (hospital or local), when NULL values are 
detected 
pima[ ,grepl( "^R_" , names( pima ) ) ]<-apply(pima[ ,grepl( "^R_" , names( pima ) ) ], 2, function(x) ifelse(is.na(x), median(x, 
na.rm=T), x)) 
pima[ ,grepl( "^RHSJ" , names( pima ) ) ]<-apply(pima[ ,grepl( "^RHSJ" , names( pima ) ) ], 2, function(x) ifelse(is.na(x), 
median(x, na.rm=T), x)) 
 
# Check datatypes of potential outcome variables 
sapply(pima[ ,grepl( "^P_" , names( pima ) ) ], function (x) table(x)) 
sapply(pima[ ,grepl( "^P_" , names( pima ) ) ], function (x) prop.table(table(x))) 
 
# Pre-processing with BoxCox, Center and Scale (remove MDR bacteria types related features) 
transform=preProcess(pima[ ,!grepl( "^P_" , names( pima ) ) ],method=c("BoxCox","center","scale")) 
 
#generate new dataset after applying transformations 
pima2<-predict(transform, pima[ ,!grepl( "^P_" , names( pima ) ) ]) 
 
#Allocate back HAI MDR bacteria types to new dataset after applying transformations 
pima2$P_Acinetobacter.spp.Carbapenemos.Resistente_SANGUE72<-  
pima$P_Acinetobacter.spp.Carbapenemos.Resistente_SANGUE72 
pima2$P_Enterobacteriaceae.Carbapenemos.Resistente_SANGUE72<- 
pima$P_Enterobacteriaceae.Carbapenemos.Resistente_SANGUE72 
pima2$P_Enterococcus.faecalis.Vancomicina.Resistente_SANGUE72 <- 
pima$P_Enterococcus.faecalis.Vancomicina.Resistente_SANGUE72  
pima2$P_Enterococcus.faecium.Vancomicina.Resistente_SANGUE72 <- 
pima$P_Enterococcus.faecium.Vancomicina.Resistente_SANGUE72  
pima2$P_St..aureus.Vancomicina.Resistente_SANGUE72<-pima$P_St..aureus.Vancomicina.Resistente_SANGUE72          
pima2$P_St.aureus.Daptomicina.Resistente_SANGUE72<-pima$P_St.aureus.Daptomicina.Resistente_SANGUE72           
pima2$P_Enterobacteriaceae.ESBL.._SANGUE72<-pima$P_Enterobacteriaceae.ESBL.._SANGUE72                  
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pima2$P_Tuberculose_SANGUE72<-pima$P_Tuberculose_SANGUE72                                
pima2$P_Acinetobacter.spp.XDR_SANGUE72<-pima$P_Acinetobacter.spp.XDR_SANGUE72                      
pima2$P_Clostridium.difficile_SANGUE72<-pima$P_Clostridium.difficile_SANGUE72                       
pima2$P_Enterobacteriaceae.XDR_SANGUE72<-pima$P_Enterobacteriaceae.XDR_SANGUE72                    
pima2$P_Enterococcus.faecalis.XDR_SANGUE72<-pima$P_Enterococcus.faecalis.XDR_SANGUE72                   
pima2$P_Enterococcus.faecium.XDR_SANGUE72<-pima$P_Enterococcus.faecium.XDR_SANGUE72                    
pima2$P_Pseudomonas.aeruginosa.XDR_SANGUE72 <-pima$P_Pseudomonas.aeruginosa.XDR_SANGUE72                  
pima2$P_St..aureus.Meticilina.Resistente_SANGUE72<-pima$P_St..aureus.Meticilina.Resistente_SANGUE72           
pima2$P_Staphylococcus.aureus..XDR_SANGUE72<-pima$P_Staphylococcus.aureus..XDR_SANGUE72                  
pima2$P_Streptococcus.pneumoniae.XDR_SANGUE72<-pima$P_Streptococcus.pneumoniae.XDR_SANGUE72 
 
# before applying one-hot encoding techniques, we have to remove variables of type "factor" which have only one level because, 
otherwise, the one-hot encoding will not work 
l<-sapply(pima2,function(x)is.factor(x)) 
m<-pima2[,names(which(l=="TRUE"))] 
 
#now, we looked for the number of levels of factor variables, if these variables only have one level, we flagged them as “DROP” 
ifelse(n<-sapply(m,function(x)length(levels(x)))==1,"DROP","NODROP") 
#we manually remove the columns which were flagged as "DROP" 
pima2[,"Trimestre"]<-NULL 
pima2[,"Semestre"]<-NULL 
 
# Transform "factor columns" with one-hot encoding 
pima2 <- dummy.data.frame(pima2, names = 
c('DiaSemana','TIPO_ADMISSAO','ESPANTERIOR','SERVFISICO','SERVRESP','SEXO','DES_PROVENIENCIA','servicof_en
trada_hsj','BLOCO','DES_SALA','PRIMEIRA_CIRURGIA','GRANDE_PROCEDIMENTO','ICD9_MAIS50K','DES_ESPECIA
LIDADE'),  sep='_') 
 
# Make syntactically valid names for each feature, after one-hot encod techniques are applied, otherwise R will return errors 
names(pima2)<-make.names(names(pima2)) 
pima2<-pima 
 
        # Create only one outcome variable by combining different types of HAI MDR bacteria (in this case the variable                  
       “MDRXDRSANGUE72” will help predict positive results for HAI MDR bacteria in blood samples)*/ 
 
pima$MDRXDRSANGUE72<-ifelse( 
pima$P_Acinetobacter.spp.Carbapenemos.Resistente_SANGUE72==1  
|pima$P_Enterobacteriaceae.Carbapenemos.Resistente_SANGUE72==1  
|pima$P_Enterococcus.faecalis.Vancomicina.Resistente_SANGUE72==1   
|pima$P_Enterococcus.faecium.Vancomicina.Resistente_SANGUE72==1   
|pima$P_St..aureus.Vancomicina.Resistente_SANGUE72==1           
|pima$P_St.aureus.Daptomicina.Resistente_SANGUE72==1            
|pima$P_Enterobacteriaceae.ESBL.._SANGUE72==1                   
|pima$P_Tuberculose_SANGUE72==1                                 
|pima$P_Acinetobacter.spp.XDR_SANGUE72==1                       
|pima$P_Clostridium.difficile_SANGUE72==1                        
|pima$P_Enterobacteriaceae.XDR_SANGUE72==1                     
|pima$P_Enterococcus.faecalis.XDR_SANGUE72==1                    
|pima$P_Enterococcus.faecium.XDR_SANGUE72==1                     
|pima$P_Pseudomonas.aeruginosa.XDR_SANGUE72==1                   
|pima$P_St..aureus.Meticilina.Resistente_SANGUE72==1            
|pima$P_Staphylococcus.aureus..XDR_SANGUE72==1                   
|pima$P_Streptococcus.pneumoniae.XDR_SANGUE72==1,1, 
ifelse( 
pima$P_Acinetobacter.spp.Carbapenemos.Resistente_SANGUE72==0  
| pima$P_Enterobacteriaceae.Carbapenemos.Resistente_SANGUE72==0  
| pima$P_Enterococcus.faecalis.Vancomicina.Resistente_SANGUE72==0   
| pima$P_Enterococcus.faecium.Vancomicina.Resistente_SANGUE72==0   
| pima$P_St..aureus.Vancomicina.Resistente_SANGUE72==0           
| pima$P_St.aureus.Daptomicina.Resistente_SANGUE72==0            
| pima$P_Enterobacteriaceae.ESBL.._SANGUE72==0                   
| pima$P_Tuberculose_SANGUE72==0                                 
| pima$P_Acinetobacter.spp.XDR_SANGUE72==0                       
| pima$P_Clostridium.difficile_SANGUE72==0                        
| pima$P_Enterobacteriaceae.XDR_SANGUE72==0                     
| pima$P_Enterococcus.faecalis.XDR_SANGUE72==0                    
| pima$P_Enterococcus.faecium.XDR_SANGUE72==0                     
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| pima$P_Pseudomonas.aeruginosa.XDR_SANGUE72==0                   
| pima$P_St..aureus.Meticilina.Resistente_SANGUE72==0            
| pima$P_Staphylococcus.aureus..XDR_SANGUE72==0                   
| pima$P_Streptococcus.pneumoniae.XDR_SANGUE72==0,0,-2)) 
 
# eliminate all cases which did not had microbiological lab results related to blood samples (in this case) 
pima<-subset(pima,pima$MDRXDRSANGUE72==0 |pima$MDRXDRSANGUE72==1) 
 
/* eliminate columns which flag specific types of HAI MDR bacteria */ 
pima<-pima[ ,!grepl( "^P_" , names( pima ) ) ] 
 
/* Convert outcome variable to Factor datatype */ 
pima$MDRXDRSANGUE72<-factor(pima$MDRXDRSANGUE72,levels=c(1,0),labels=c("Infectado","NãoInfetado")) 
 
Figure A 1: R code related to the systematic implementation of all Feature engineering tasks – 
(some text in Portuguese). 
 
# Split the dataset into training and test datasets using stratified random sampling 
 
trainIndex <- createDataPartition( 
## specify the outcome column 
pimasangue72$MDRXDRSANGUE72,  
## specify he percentage of data that goes into the training set 
p = 0.7, list=FALSE) 
trainingdata <- pimasangue72[trainIndex, ] 
testdata <- pimasangue72[-trainIndex, ] 
 
# Specify the type of control to apply while training (resampling) 
fitControl <- trainControl( 
# apply 10 fold-CV while training 
                          method = "cv", number=10,   
                        ## Estimate class probabilities 
                           classProbs = TRUE,  summaryFunction = twoClassSummary) 
 
# Example of the train function, in this case, random forest parallel algorithm is used by specifying the method “parRF” 
trainedmodel <- train(y = trainingdata$MDRXDRSANGUE72, x = trainingdata[, colnames(trainingdata) != 
'MDRXDRSANGUE72'],  
method = "parRF",trControl = fitControl,  
metric = "ROC") 
 
Figure A 2: R code related to a common framework that was used to train all models used in this 
work, by applying the functions available in the Caret package. 
 
# Activating parallel execution libraries 
library(doParallel)  
# Initiate cluster, reserve one core for operating system activities 
cl <- makeCluster(detectCores()-2, type='PSOCK') 
registerDoParallel(cl)  
#This comand checks if all the system cores (-1) are available for R# 
 getDoParWorkers() 
# The result, returns 7 cores available 
# After the execution, the cluster is closed 
registerDoSEQ() 
on.exit(stopCluster(cl)) 
 
Figure A 3: R code related to the implementation of parallelization frameworks while training 
algorithms in R Studio.  
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8.3 APPENDIX 3: ADDITIONAL REFERENCE TABLES 
Irrelevant Feature Removed Class Reason 
X28_seg Medication Only had NULL values 
X36_seg Medication Only had NULL values 
X53_seg Medication Only had NULL values 
X65_seg Medication Only had NULL values 
X86_seg Medication Only had NULL values 
X94_seg Medication Only had NULL values 
X103_seg Medication Only had NULL values 
X111_seg Medication Only had NULL values 
X123_seg Medication Only had NULL values 
X124_seg Medication Only had NULL values 
X132_seg Medication Only had NULL values 
X136_seg Medication Only had NULL values 
X191_seg Medication Only had NULL values 
X193_seg Medication Only had NULL values 
X209_seg Medication Only had NULL values 
X28_acm Medication Only had NULL values 
X36_acm Medication Only had NULL values 
X53_acm Medication Only had NULL values 
X65_acm Medication Only had NULL values 
X86_acm Medication Only had NULL values 
X94_acm Medication Only had NULL values 
X103_acm Medication Only had NULL values 
X111_acm Medication Only had NULL values 
X123_acm Medication Only had NULL values 
X124_acm Medication Only had NULL values 
X132_acm Medication Only had NULL values 
X136_acm Medication Only had NULL values 
X191_acm Medication Only had NULL values 
X193_acm Medication Only had NULL values 
X209_acm Medication Only had NULL values 
R_Acinetobacter.Gentamicin Department Microorganism Resistance Only had NULL values 
R_Enterobacter.Cefuroxime Department Microorganism Resistance Only had NULL values 
R_Enterobacter.Nitrofurantoína Department Microorganism Resistance Only had NULL values 
R_Enterococcus.faecalis.Ciprofloxacina Department Microorganism Resistance Only had NULL values 
R_Enterococcus.faecalis.Daptomycin Department Microorganism Resistance Only had NULL values 
R_Enterococcus.faecalis.Levofloxacina Department Microorganism Resistance Only had NULL values 
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Irrelevant Feature Removed Class Reason 
R_Enterococcus.faecalis.Nitrofurantoína Department Microorganism Resistance Only had NULL values 
R_Enterococcus.faecalis.Norfloxacina Department Microorganism Resistance Only had NULL values 
R_Enterococcus.faecalis.Penicilina Department Microorganism Resistance Only had NULL values 
R_Enterococcus.faecalis.Tetraciclina Department Microorganism Resistance Only had NULL values 
R_Klebsiella.Aztreonam Department Microorganism Resistance Only had NULL values 
R_Klebsiella.Cloranfenicol Department Microorganism Resistance Only had NULL values 
R_Klebsiella.Nitrofurantoína Department Microorganism Resistance Only had NULL values 
R_Klebsiella.Norfloxacina Department Microorganism Resistance Only had NULL values 
R_Klebsiella.Ofloxacina Department Microorganism Resistance Only had NULL values 
R_Klebsiella.Piperacilina Department Microorganism Resistance Only had NULL values 
R_Klebsiella.Tetraciclina Department Microorganism Resistance Only had NULL values 
R_Klebsiella.Ticarcillin Department Microorganism Resistance Only had NULL values 
R_Klebsiella.Ticarcillin.CA Department Microorganism Resistance Only had NULL values 
R_OutrosMicroorganismos.Amicacina..1ug..ml. Department Microorganism Resistance Only had NULL values 
R_OutrosMicroorganismos.Aztreonam Department Microorganism Resistance Only had NULL values 
R_OutrosMicroorganismos.Etionamida..5.0ug..ml. Department Microorganism Resistance Only had NULL values 
R_OutrosMicroorganismos.Linezolide..1.0ug..ml. Department Microorganism Resistance Only had NULL values 
R_OutrosMicroorganismos.Ofloxacina..2.0ug..ml. Department Microorganism Resistance Only had NULL values 
R_OutrosMicroorganismos.Piperacilina Department Microorganism Resistance Only had NULL values 
R_OutrosMicroorganismos.Ticarcillin Department Microorganism Resistance Only had NULL values 
R_OutrosMicroorganismos.Ticarcillin.CA Department Microorganism Resistance Only had NULL values 
R_Proteus.mirabilis.Cefepime Department Microorganism Resistance Only had NULL values 
R_Proteus.mirabilis.Cloranfenicol Department Microorganism Resistance Only had NULL values 
R_Proteus.mirabilis.Imipenem Department Microorganism Resistance Only had NULL values 
R_Proteus.mirabilis.Nitrofurantoína Department Microorganism Resistance Only had NULL values 
R_Proteus.mirabilis.Norfloxacina Department Microorganism Resistance Only had NULL values 
R_Proteus.mirabilis.Ofloxacina Department Microorganism Resistance Only had NULL values 
R_Proteus.mirabilis.Tetraciclina Department Microorganism Resistance Only had NULL values 
R_Pseudomonas.aeruginosa.Gentamicin Department Microorganism Resistance Only had NULL values 
R_Pseudomonas.aeruginosa.Levofloxacina Department Microorganism Resistance Only had NULL values 
R_Pseudomonas.aeruginosa.Norfloxacina Department Microorganism Resistance Only had NULL values 
R_Pseudomonas.aeruginosa.Ofloxacina Department Microorganism Resistance Only had NULL values 
R_Staphylococcus.aureus..Mupirocina Department Microorganism Resistance Only had NULL values 
RHSJ_Acinetobacter.Gentamicin Hospital Microorganism Resistance Only had NULL values 
RHSJ_Enterobacter.Cefuroxime Hospital Microorganism Resistance Only had NULL values 
RHSJ_Enterobacter.Nitrofurantoína Hospital Microorganism Resistance Only had NULL values 
RHSJ_Enterococcus.faecalis.Ciprofloxacina Hospital Microorganism Resistance Only had NULL values 
RHSJ_Enterococcus.faecalis.Daptomycin Hospital Microorganism Resistance Only had NULL values 
RHSJ_Enterococcus.faecalis.Levofloxacina Hospital Microorganism Resistance Only had NULL values 
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Irrelevant Feature Removed Class Reason 
RHSJ_Enterococcus.faecalis.Nitrofurantoína Hospital Microorganism Resistance Only had NULL values 
RHSJ_Enterococcus.faecalis.Norfloxacina Hospital Microorganism Resistance Only had NULL values 
RHSJ_Enterococcus.faecalis.Penicilina Hospital Microorganism Resistance Only had NULL values 
RHSJ_Enterococcus.faecalis.Tetraciclina Hospital Microorganism Resistance Only had NULL values 
RHSJ_Klebsiella.Aztreonam Hospital Microorganism Resistance Only had NULL values 
RHSJ_Klebsiella.Cloranfenicol Hospital Microorganism Resistance Only had NULL values 
RHSJ_Klebsiella.Nitrofurantoína Hospital Microorganism Resistance Only had NULL values 
RHSJ_Klebsiella.Norfloxacina Hospital Microorganism Resistance Only had NULL values 
RHSJ_Klebsiella.Ofloxacina Hospital Microorganism Resistance Only had NULL values 
RHSJ_Klebsiella.Piperacilina Hospital Microorganism Resistance Only had NULL values 
RHSJ_Klebsiella.Tetraciclina Hospital Microorganism Resistance Only had NULL values 
RHSJ_Klebsiella.Ticarcillin Hospital Microorganism Resistance Only had NULL values 
RHSJ_Klebsiella.Ticarcillin.CA Hospital Microorganism Resistance Only had NULL values 
RHSJ_OutrosMicroorganismos.Amicacina..1ug..ml. Hospital Microorganism Resistance Only had NULL values 
RHSJ_OutrosMicroorganismos.Aztreonam Hospital Microorganism Resistance Only had NULL values 
RHSJ_OutrosMicroorganismos.Etionamida..5.0ug..ml. Hospital Microorganism Resistance Only had NULL values 
RHSJ_OutrosMicroorganismos.Linezolide..1.0ug..ml. Hospital Microorganism Resistance Only had NULL values 
RHSJ_OutrosMicroorganismos.Mupirocina Hospital Microorganism Resistance Only had NULL values 
RHSJ_OutrosMicroorganismos.Ofloxacina..2.0ug..ml. Hospital Microorganism Resistance Only had NULL values 
RHSJ_OutrosMicroorganismos.Piperacilina Hospital Microorganism Resistance Only had NULL values 
RHSJ_OutrosMicroorganismos.Ticarcillin Hospital Microorganism Resistance Only had NULL values 
RHSJ_OutrosMicroorganismos.Ticarcillin.CA Hospital Microorganism Resistance Only had NULL values 
RHSJ_Proteus.mirabilis.Cefepime Hospital Microorganism Resistance Only had NULL values 
RHSJ_Proteus.mirabilis.Cloranfenicol Hospital Microorganism Resistance Only had NULL values 
RHSJ_Proteus.mirabilis.Imipenem Hospital Microorganism Resistance Only had NULL values 
RHSJ_Proteus.mirabilis.Nitrofurantoína Hospital Microorganism Resistance Only had NULL values 
RHSJ_Proteus.mirabilis.Norfloxacina Hospital Microorganism Resistance Only had NULL values 
RHSJ_Proteus.mirabilis.Ofloxacina Hospital Microorganism Resistance Only had NULL values 
RHSJ_Proteus.mirabilis.Tetraciclina Hospital Microorganism Resistance Only had NULL values 
RHSJ_Pseudomonas.aeruginosa.Gentamicin Hospital Microorganism Resistance Only had NULL values 
RHSJ_Pseudomonas.aeruginosa.Levofloxacina Hospital Microorganism Resistance Only had NULL values 
RHSJ_Pseudomonas.aeruginosa.Norfloxacina Hospital Microorganism Resistance Only had NULL values 
RHSJ_Pseudomonas.aeruginosa.Ofloxacina Hospital Microorganism Resistance Only had NULL values 
RHSJ_Staphylococcus.aureus..Mupirocina Hospital Microorganism Resistance Only had NULL values 
 
Table A 1: Short description of columns removed from original dataset due to NULL values (all 
values were NULL). 
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Dataset Features with Zero Variance 
Cateter_Venoso_Central_SaT_Jugular 
X28_seg 
X36_seg 
X53_seg 
X65_seg 
X103_seg 
X111_seg 
X123_seg 
X136_seg 
X193_seg 
X28_acm 
X36_acm 
X53_acm 
X65_acm 
X103_acm 
X111_acm 
X123_acm 
X136_acm 
X193_acm 
R_Acinetobacter.Gentamicin 
R_Enterobacter.Cefuroxime 
R_Enterobacter.Nitrofurantoína 
R_Enterococcus.faecalis.Ciprofloxacina 
R_Enterococcus.faecalis.Daptomycin 
R_Enterococcus.faecalis.Levofloxacina 
R_Enterococcus.faecalis.Nitrofurantoína 
R_Enterococcus.faecalis.Norfloxacina 
R_Enterococcus.faecalis.Penicilina 
R_Enterococcus.faecalis.Tetraciclina 
R_Klebsiella.Aztreonam 
R_Klebsiella.Cloranfenicol 
R_Klebsiella.Nitrofurantoína 
R_Klebsiella.Norfloxacina 
R_Klebsiella.Ofloxacina 
R_Klebsiella.Piperacilina 
R_Klebsiella.Tetraciclina 
R_Klebsiella.Ticarcillin 
R_Klebsiella.Ticarcillin.CA 
R_OutrosMicroorganismos.Amicacina..1ug..ml. 
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Dataset Features with Zero Variance 
R_OutrosMicroorganismos.Aztreonam 
R_OutrosMicroorganismos.Etionamida..5.0ug..ml. 
R_OutrosMicroorganismos.Linezolide..1.0ug..ml. 
R_OutrosMicroorganismos.Ofloxacina..2.0ug..ml. 
R_OutrosMicroorganismos.Piperacilina 
R_OutrosMicroorganismos.Ticarcillin 
R_OutrosMicroorganismos.Ticarcillin.CA 
R_Proteus.mirabilis.Cefepime 
R_Proteus.mirabilis.Cloranfenicol 
R_Proteus.mirabilis.Imipenem 
R_Proteus.mirabilis.Nitrofurantoína 
R_Proteus.mirabilis.Norfloxacina 
R_Proteus.mirabilis.Ofloxacina 
R_Proteus.mirabilis.Tetraciclina 
R_Pseudomonas.aeruginosa.Gentamicin 
R_Pseudomonas.aeruginosa.Levofloxacina 
R_Pseudomonas.aeruginosa.Norfloxacina 
R_Pseudomonas.aeruginosa.Ofloxacina 
R_Staphylococcus.aureus..Mupirocina 
RHSJ_Acinetobacter.Gentamicin 
RHSJ_Enterobacter.Cefuroxime 
RHSJ_Enterobacter.Nitrofurantoína 
RHSJ_Enterococcus.faecalis.Ciprofloxacina 
RHSJ_Enterococcus.faecalis.Daptomycin 
RHSJ_Enterococcus.faecalis.Levofloxacina 
RHSJ_Enterococcus.faecalis.Nitrofurantoína 
RHSJ_Enterococcus.faecalis.Norfloxacina 
RHSJ_Enterococcus.faecalis.Penicilina 
RHSJ_Enterococcus.faecalis.Tetraciclina 
RHSJ_Klebsiella.Aztreonam 
RHSJ_Klebsiella.Cloranfenicol 
RHSJ_Klebsiella.Nitrofurantoína 
RHSJ_Klebsiella.Norfloxacina 
RHSJ_Klebsiella.Ofloxacina 
RHSJ_Klebsiella.Piperacilina 
RHSJ_Klebsiella.Tetraciclina 
RHSJ_Klebsiella.Ticarcillin 
RHSJ_Klebsiella.Ticarcillin.CA 
RHSJ_OutrosMicroorganismos.Amicacina..1ug..ml. 
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Dataset Features with Zero Variance 
RHSJ_OutrosMicroorganismos.Aztreonam 
RHSJ_OutrosMicroorganismos.Etionamida..5.0ug..ml. 
RHSJ_OutrosMicroorganismos.Linezolide..1.0ug..ml. 
RHSJ_OutrosMicroorganismos.Mupirocina 
RHSJ_OutrosMicroorganismos.Ofloxacina..2.0ug..ml. 
RHSJ_OutrosMicroorganismos.Piperacilina 
RHSJ_OutrosMicroorganismos.Ticarcillin 
RHSJ_OutrosMicroorganismos.Ticarcillin.CA 
RHSJ_Proteus.mirabilis.Cefepime 
RHSJ_Proteus.mirabilis.Cloranfenicol 
RHSJ_Proteus.mirabilis.Imipenem 
RHSJ_Proteus.mirabilis.Nitrofurantoína 
RHSJ_Proteus.mirabilis.Norfloxacina 
RHSJ_Proteus.mirabilis.Ofloxacina 
RHSJ_Proteus.mirabilis.Tetraciclina 
RHSJ_Pseudomonas.aeruginosa.Gentamicin 
RHSJ_Pseudomonas.aeruginosa.Levofloxacina 
RHSJ_Pseudomonas.aeruginosa.Norfloxacina 
RHSJ_Pseudomonas.aeruginosa.Ofloxacina 
RHSJ_Staphylococcus.aureus..Mupirocina 
RHSJ_Enterococcus.faecalis.Levofloxacina 
RHSJ_Enterococcus.faecalis.Nitrofurantoína 
RHSJ_Enterococcus.faecalis.Norfloxacina 
RHSJ_Enterococcus.faecalis.Penicilina 
RHSJ_Enterococcus.faecalis.Tetraciclina 
RHSJ_Enterococcus.faecium.Azitromicina 
RHSJ_Enterococcus.faecium.Claritromicina 
RHSJ_Escherichia.coli.Cefalotina 
RHSJ_Escherichia.coli.Cloranfenicol 
RHSJ_Escherichia.coli.Nitrofurantoína 
RHSJ_Escherichia.coli.Norfloxacina 
RHSJ_Escherichia.coli.Ofloxacina 
RHSJ_Escherichia.coli.Tetraciclina 
RHSJ_Klebsiella.Aztreonam 
RHSJ_Klebsiella.Cefepime 
RHSJ_Klebsiella.Cloranfenicol 
RHSJ_Klebsiella.Colistina 
RHSJ_Klebsiella.Nitrofurantoína 
RHSJ_Klebsiella.Norfloxacina 
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Dataset Features with Zero Variance 
RHSJ_Klebsiella.Ofloxacina 
RHSJ_Klebsiella.Piperacilina 
RHSJ_Klebsiella.Tetraciclina 
RHSJ_Klebsiella.Ticarcillin 
RHSJ_Klebsiella.Ticarcillin.CA 
RHSJ_Klebsiella.Tigecycline 
RHSJ_OutrosMicroorganismos.Amicacina..1ug..ml. 
RHSJ_OutrosMicroorganismos.Azitromicina 
RHSJ_OutrosMicroorganismos.Aztreonam 
RHSJ_OutrosMicroorganismos.Cefalotina 
RHSJ_OutrosMicroorganismos.Claritromicina 
RHSJ_OutrosMicroorganismos.Colistina 
RHSJ_OutrosMicroorganismos.Estreptomicina..1ug..ml. 
RHSJ_OutrosMicroorganismos.Etambutol..5.0ug..ml. 
RHSJ_OutrosMicroorganismos.Etionamida..5.0ug..ml. 
RHSJ_OutrosMicroorganismos.Isoniazida..0.1ug..ml. 
RHSJ_OutrosMicroorganismos.Linezolide..1.0ug..ml. 
RHSJ_OutrosMicroorganismos.Mupirocina 
RHSJ_OutrosMicroorganismos.Ofloxacina 
RHSJ_OutrosMicroorganismos.Ofloxacina..2.0ug..ml. 
RHSJ_OutrosMicroorganismos.Piperacilina 
RHSJ_OutrosMicroorganismos.Pirazinamida.100ug..ml. 
RHSJ_OutrosMicroorganismos.Rifampicina..1.0ug..ml. 
RHSJ_OutrosMicroorganismos.Streptomycin.High.Level..synergy. 
RHSJ_OutrosMicroorganismos.Ticarcillin 
RHSJ_OutrosMicroorganismos.Ticarcillin.CA 
RHSJ_Proteus.mirabilis.Cefepime 
RHSJ_Proteus.mirabilis.Cloranfenicol 
RHSJ_Proteus.mirabilis.Imipenem 
RHSJ_Proteus.mirabilis.Nitrofurantoína 
RHSJ_Proteus.mirabilis.Norfloxacina 
RHSJ_Proteus.mirabilis.Ofloxacina 
RHSJ_Proteus.mirabilis.Tetraciclina 
RHSJ_Pseudomonas.aeruginosa.Gentamicin 
RHSJ_Pseudomonas.aeruginosa.Levofloxacina 
RHSJ_Pseudomonas.aeruginosa.Norfloxacina 
RHSJ_Pseudomonas.aeruginosa.Ofloxacina 
RHSJ_Staphylococcus.aureus..Mupirocina 
RHSJ_Streptococcus.pneumoniae.Cefotaxime..non.meningitis. 
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Dataset Features with Zero Variance 
RHSJ_Streptococcus.pneumoniae.Ceftriaxone..non.meningitis. 
RHSJ_Streptococcus.pneumoniae.Clindamicina 
RHSJ_Streptococcus.pneumoniae.Cloranfenicol 
RHSJ_Streptococcus.pneumoniae.Eritromicina 
RHSJ_Streptococcus.pneumoniae.Levofloxacina 
RHSJ_Streptococcus.pneumoniae.Linezolide 
RHSJ_Streptococcus.pneumoniae.Ofloxacina 
RHSJ_Streptococcus.pneumoniae.Penicilina 
RHSJ_Streptococcus.pneumoniae.Tetraciclina 
RHSJ_Streptococcus.pneumoniae.Trimetoprim.Sulfa 
RHSJ_Streptococcus.pneumoniae.Vancomicina 
 
Table A 2: Short description of columns removed from original dataset due to zero variance 
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